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ABSTRACT 
This study is composed of two parts. In the first part, we discussed nitrilimine-
alkene cycloaddition for protein labeling. The mechanism of this nitrilimine-alkene 
cycloaddition was proposed, and thereby the best experimental condition for this protein 
labeling approach was investigated. The transient formation of nitrilimine in aqueous 
conditions is greatly influenced by pH and chloride. In basic conditions (pH 10) with no 
chloride, a diarylnitrilimine precursor readily ionizes to form diarylnitrilimine that reacts 
almost instantly with an acrylamidecontaining protein and fluorescently labels it.  
In the second part, a novel method for the synthesis of phage-displayed cyclic 
peptide libraries is presented. Cyclic peptide drugs are appealing in the drug discovery 
research area due to their unique advantages including high affinity, high specificity, low 
toxicity, and high cellular and serum stability. In order to identify cyclic peptides as 
therapeutic agents, during my graduate study I have developed a phage display-based 
methodology that integrates the genetic noncanonical amino acid (ncAA) mutagenesis 
technique for the synthesis of novel phage-displayed cyclic peptides through simultaneous 
1,4-addition between a cysteine thiol group and acrylamide moiety in Nε-acryloyl-lysine 
(AcrK), a ncAA. Both cysteine and AcrK are genetically coded. The success of using a 
cysteine and an AcrK to cyclic a peptide in a model protein and phages was validated by 
various approaches. In order to afford a library, a phage-displayed cyclic peptide library 
was constructed by inserting a consecutive but sequence-randomized 6-mer peptide 
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flanked by an amino side cysteine and a carboxyl side AcrK. Panning of the synthesized 
phage-displayed cyclic peptide library was performed against two target proteins that are 
tobacco etch virus (TEV) protease and histone deacetylase 8 (HDAC8). A lot of high-
affinity phage clones were isolated and collected. DNA sequencing of these selected clones 
led to the identification of several peptides that potentially inhibit TEV protease and 
HDAC8. To confirm their potencies as inhibitors, abundant peptides and their fluorophore-
conjugated derivatives were synthesized through solid-phase peptide synthesis (SPPS). 
Measurements of fluorescence polarization change and IC50 value of these peptides when 
they bound to TEV protease and HDAC8 were performed. 
Overall, we have mechanistically characterized the nitrilimine-alkene 
cycloaddition reaction and developed a novel approach for the synthesis of phage-
displayed cyclic peptide libraries. The selection of displayed peptides against TEV protease 
and HDAC8 has resulted multiple peptides that display high potencies against these two 
enzymes. 
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NOMENCLATURE 
AcrK Nε-acryloyl-L-lysine 
AMC 7-Amino-4-methylcoumarin 
CrtK Nε-crotonyl-L-lysine 
FAM 5-Carboxyfluorescein 
FP Fluorescence polarization 
HATs Histone acetyltransferases 
HDACs Histone deacetylases 
NCAA Non-canonical amino acids 
PBS Phosphate-buffered saline 
PCR Polymerase chain reaction  
SPPS Solid phase peptide synthesis 
TEV Tobacco etch virus 
Ni-NTA Nickel nitrilotriacetic acid 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
sfGFP Superfolder green fluorescent protein 
SAHA Suberoylanilide hydroxamic acid 
Tris Tris(hydroxymethyl)aminomethane 
TSA Trichostatin A 
WT Wild type 
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CHAPTER I 
INTRODUCTION 
Cyclic Peptide 
Small molecules and biologics are two categories of currently widely used drugs. 
Small molecule drugs are defined as small size drugs with molecular weights less than 500 
Da, while biologics have molecular weights larger than 5000 Da. Compared to large 
biologics such as insulin and antibodies, small molecules have better cell permeability and 
metabolic stability. Small molecules are more suitable for oral delivery while protein 
therapeutics require injection or intranasal delivery. However, because of less structure 
complexity, small molecules don’t perform well in target selectivity as protein therapeutics 
and they may have more side-effects.1 Thus, there is a growing interest in the discovery of 
a new kind of drug.  
With a medium molecular weight between small molecules and large biologics (500 
Da - 5000 Da), peptide-based molecules are recognized as great success in novel 
therapeutics with high selectivity and affinity. It combines favorable properties of small 
molecule drugs such as good bioavailability and stability, and advantages of biologics such 
as high specificity. Moreover, compared to small molecules drugs, peptide-based 
molecules have lower toxicity and low accumulation in tissues due to amino-acid based 
structure. Peptide-based molecules began to emerge in mid-20th century. After decades of 
research and development, more than 7000 peptides have been identified, more than 500 
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peptide-based drugs are in preclinical development, and around 140 peptide-based drugs 
have been applied in clinical trials.2 
Among all peptides, cyclic peptide is a special category of polypeptide with ring 
structure. Compared to traditional linear counterparts, cyclic peptides have more 
advantages in stability because macrocyclic structures is helpful in forming intramolecular 
hydrogen bonds, shielding polar atoms from solvent, and thereby have limited 
conformational flexibility.3 The rigidity of structure also decreases the entropy and allows 
high binding affinity. In addition, due to lack of cleavable terminal amino group and 
carboxyl group, amide-linked cyclization provides protection against proteolytic 
degradation from exo- and endo-peptideases.4 Because of these dominant advantages, more 
and more cyclic peptide drugs emerge in therapeutic market. Currently, more than 40 cyclic 
peptide therapeutics are in clinical trials.5 
There are several common kinds of macrocyclization method, head-to-tail, side-
chain-to-tail and side-chain-to-side-chain reactions. Head-to-tail cyclization formed amide 
bond through lactonization. Side-chain-to-side-chain cyclization includes reactions 
between sulfhydryl groups of cysteines, reactions between an amino group of lysine and a 
carboxyl group of aspartic acid or glutamic acid. It may also occur between canonical 
amino acid and non-canonical amino acid or between non-canonical amino acids. Recently 
Dr. Liu and co-workers has demonstrated the success of 1,4-addition of Nε-acryloyl-l-
lysine, a non-canonical amino acid, with thiol nucleophiles in protein labeling.6 This study 
expands the chemical diversity of peptide cyclization approach.  
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Phage Display 
The phage display system, as first described by George Smith in 1985 7, is one of 
the most powerful methodologies in drug discovery. The phage display technology is 
designed to express foreign peptides as fusion proteins on the surface of filamentous 
phages. In general, a phage library with randomized amino acids at one or more positions 
is capable of having large diversity, containing as many as 1013 different variants. Phage 
selection is also rapid, convenient and efficient in producing large variants and amounts of 
peptides or proteins. The selection and isolation of specific peptides with high affinity can 
be achieved through biopanning of the very diverse phage libraries against immobilized 
targets. Usually, the enrichment of selected phages can be generated by passage and 
expression through an E. coli cell host. To enable high-affinity binding with a specific 
disease-related target, iterative rounds of the selection are performed. Finally, the selected 
phages are subjected to DNA sequencing to determine the peptide sequences. Further study 
of protein-ligand interactions potentially leads to pharmaceutical applications.  
In the phage display system, the best-studied filamentous bacteriophage is F pilus-
specific phage, also known as f1, fd and M13 (Figure 1).8 The most commonly used 
approach is to use a filamentous phage to express a peptide fused to a major coat protein 
(pVIII) or minor coat protein (pIII). The pVIII display system has a high valency (about 
2700 copies per virion) and only 10% can be utilized as fusion peptides.9 In comparison, 
the pIII display system has lower valency than the pVIII system (less than 5 copies per 
virion). A high-valency system typically results in a selection of low affinity ligands, while 
lower valency ensures a selection of high affinity ligands. Moreover, during the expression 
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step, pIII can be knocked out while pVIII cannot. Therefore, to guarantee the high-affinity 
selection, most peptides and proteins are displayed with pIII proteins. In genetic 
engineering of phage libraries, phagemid and phages are two mainly used vectors, 
containing replication origins, gene 3 and antibiotic resistance gene. Compared to phages, 
phagemids are more commonly used for several advantages, such as smaller genomes, 
more restriction enzyme recognition sites for gene engineering, higher efficiency and easier 
control in DNA level.10 However, phagemids cannot produce progeny phage particles by 
themselves. For the conversion of phagemids to phage particles, helper phages such as 
M13K07 and VSM13 are required to provide packaging of phagemid DNAs. 
Life circles of filamentous phages include bacterial infection and replication. 
Unlike other DNA phages which inject their DNA into the host cells, filamentous phages 
inject the entire phage particles. For a host cell like Escherichia coli., F pilus enables the 
binding of pIII protein, and membrane protein TolA, TolQ and TolR are receptors. After 
entry into the host cell, the ssDNA of M13 enables the replication and amplification.  
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Figure 1 Structure of M13 phage. 
 
Cyclization of Side Chains in Phage Display 
In recent years, there is much current interest in expanding cyclization methods 
through side chains in phage display system. Although in natural, head-to-tail lactonization 
is a common way to generate macrocyclic peptides, it is not favorable by phage-displayed 
cyclic peptides due to the lack of free C-terminus on phages.7 Two strategies have been 
reported to generate phage-displayed macrocyclic libraries, one through internal side-chain 
reactions and the other through chemical linkers. For the former one, the most widely used 
approach is through a disulfide bond between cysteines of a fusion peptide.  Ghosh and co-
workers demonstrated a method of constructing a 6-mer cyclic library Cys-(Xxx)6-Cys 
(Xxx represents randomized amino acids) and screened this library against protein kinase 
A (Figure 2A).11  Results show that cyclo(CTFRVFGC) is the most abundant sequence 
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with IC50 = 57 ± 3 μM. However, this disulfide bond is not stable in reducing environment, 
and thereby some organic linkers are designed to connect two cysteines.  
To make cyclic phage-displayed libraries through ligation of chemical linkers, 
Szostak and co-workers recently described a method to generate a cyclic phage library 
containing 10 randomized amino acids through the reaction between two cysteines and an 
organic linker dibromoxylene(Figure 2B).12 Winter and co-workers also described a phage 
strategy to generate a bicyclic peptide library through an organic linker tris-
(bromomethyl)benzene which reacts with three cysteines (Figure 2C).13 The peptide 
sequence of the phage library they designed is Cys-(Xxx)6-Cys-(Xxx)6-Cys. After the 
cyclization with tris-(bromomethyl)benzene, the selected bicyclic peptide has ki = 1.5 nM 
towards human plasma kallikrein. To expand the chemical diversity of cyclization, more 
non-canonical amino acids are incorporated into the peptide. Schultz and co-workers have 
already incorporated several non-canonical amino acids into the phage display system14, 
showing that the incorporation of some certain non-canonical amino acids could 
dramatically improve the ligand binding affinity towards specific targets.15 Besides bromo-
cysteine reactions, Derda and co-workers described an efficient way of cyclization using 
dichloro-oxime (DCO) derivatives as a cyclization linker.16 The reaction is quite clean and 
highly chemo- and regio-selective.  
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Figure 2 Cyclization methods to construct cyclic phage library. (A) Cyclization through a 
disulfide bond; (B) Cyclization through an organic linker dibromoxylene between two 
cysteines; (C) Cyclization through an organic linker tris-(bromomethyl)benzene. 
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Genetic Incorporation of Non-Canonical Amino Acids 
There are twenty canonical amino acids found in natural. To expand the chemical 
diversity of amino acids, peptides and proteins, efforts have been made in site-specific 
incorporation of non-canonical amino acids (NCAAs) both in vitro and in vivo. Early 
efforts are focused on canonical machinery to suppress sense codon and incorporate 
NCAAs which are similar to canonical amino acids. This method has been limited to the 
strict similarity between incorporated NCAAs and canonical amino acids, as well as the 
competition from canonical amino acids. Nonsense codon suppression including stop 
codon (amber codon UAG, opal codon UGA and ochre codon UAA) suppression and 
quadruplet codon suppression means reading the nonsense codon as the sense codon to 
insert NCAAs via an orthogonal aminoacyl-tRNA synthetase (AARS)-tRNA pairs. 
Compared to sense codon suppression, this strategy has greater flexibility and has been 
applied in incorporation of more than 150 different NCAAs. Pioneering efforts made by 
Schultz and co-workers utilized a MjTyrRS-𝑡𝑅𝑁𝐴஼௎஺
்௬௥  pair and allowed the site-specific 
insertion of NCAAs at amber codon and bulk expression of proteins in vivo via host cell's 
own translational machinery.17   
The tRNA of the 22nd proteinogenic amino acid, pyrrolysine, is also chosen for its 
success in reassign UAG codon to encode a NCAA. In 2002, pyrrolysine was firstly 
discovered in Methanosarcina barkeri and a specific aminoacyl-tRNA synthetase, 
Pyrrolysyl-tRNA synthetase (PylRS), was reported to encode pyrrolysine with the amber 
codon18,19 . Due to its high substrate side chain promiscuity and low selectivity toward α-
amine and the tRNA anti-codon, PylRS and its orthogonal suppressor tRNAPyl have been 
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harnessed for the genetic code expansion.19 Hereby more NCAAs with hard-to-introduced 
functional group can be incorporated to the recombinant proteins by PylRS-tRNAPyl pairs 
or their mutants. As achieved by Liu and co-workers, the mutants of PylRS and their 
cognitive tRNA pairs have been successfully used in the incorporation of diverse lysine 
and phenylalanine derivatives.6  This translation process can be described as Figure 3. 
Under the catalysis of PylRS or its mutant, Pyl or other corresponding NCAA is transferred 
to the amber codon tRNA. The aminoacylated tRNA is delivered to the A site of the 
ribosome by the elongation factor, and further to the P site to couple its uncharged amino 
acid. Translation will not stop until the ribosome encounters a “real” stop codon.  
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Figure 3 Machinery of NCAA incorporation using a pyrrolysine model 
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Biorthogonal Reactions in Protein Labeling 
Selective labeling with chemical probes has emerged as an indispensable tool to 
investigate structure, function and internal or external interactions of proteins. Success of 
protein labeling requires biorthogonal reactions only with target functional group at a 
defined site. Reaction conditions should also be mild and have little or no toxicity to living 
cells. Additionally, reaction conditions such as aqueous solvent, neutral pH and proper 
temperature are also needed. Moreover, the incorporation of NCAAs bearing diverse 
biorthogonal functionalities allows site-specific labeling of recombinant proteins in vitro 
and in vivo. 
 In recent decades, researchers have made tremendous progress on the discovery of 
biorthogonal reactions with chemo- and regio-selectivity. Amongst these reactions, click 
reactions have raised much focus due to their high selectivity, reliability and the ability to 
meet criterion of protein labeling as mentioned earlier. Click reactions include 1,3-dipolar 
cycloaddtion, Staudinger reaction, copper(I)-catalyzed alkyne-azide cycloaddition 
(CuAAC), Diels–Alder cycloaddition, strain-promoted azide alkyne cycloaddition 
(SPAAC) and so on.  
Amongst these click reactions, aizde derivatives play very important roles due to 
their unique advantages including small size, inert nature and high selectivity when 
reacting with phosphines, alkynes and alkenes. General ligations with azides include 
Staudinger ligation, copper catalyzed azide-alkyne cycloaddition (CuAAC) and copper-
free azide-alkyne cycloaddition (Figure 4).20 
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Figure 4 General ligation of azide derivatives  
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Staudinger ligation between azides and triarylphosphines with a ester group to yield 
amines, reported by Bertozzi and coworkers in 2004, is the first bioconjugation 
methodology applied in living system.21 Later, the traceless Staudinger ligation was 
developed, where phosphine oxide is excised during the formation of amide bond. 
However, the application of Staudinger ligation as a biorthogonal reaction is limited for  
the low reaction rate (~ 10-3 M-1 s-1) and phosphine reagents’ susceptibility to oxidation. 22 
Huisgen’s pioneering efforts in 1,3-dipolar cycloaddition reaction, where azides act 
as 1,3-dipoles and react with alkyes to yield triazoles under the catalysis of copper(I) salts, 
has had a profound impact in protein labeling. This CuAAC reaction is at least 25 times 
faster than the Staudinger ligation.22 However, the toxicity of copper which may be harmful 
to living systems is still a big problem. Thereby reactions without catalysis from copper 
have raised more focus. These reactions are the so-called “Cu-free click reactions”. One 
example is strain-promoted alkyne-azide cycloaddition (SPAAC) which can avoid copper 
catalysis by introducing ring strain into the alkyne.23  
Nitrile imine is also an essence synthetic intermediate of 1,3-dipolar cycloadditions 
leading to pyrazolines, pyrazoles and other organic compounds.24 Non-stabilized nitrile 
imines have six different structures: 1,3-dipolar, allenic, propargylic, reverse 1,3-dipolar, 
1,3-diradical and carbonic, as shown in Figure 5.25 Sibi and co-workers firstly reported the 
highly regio- and enantio-selective  asymmetric 1,3-diplar cycloaddition of nitrile imines 
to olefins in 2005.26  
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Figure 5 Fundamental structures of nitrile imine  
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In recent years researchers have reported a variety of methods to generate nitrile 
imine from different precursors, including 1) heating or photolysis of tetrazoles, 2) catalytic 
oxidation of aldehyde, 3) based-induced dehydrohalogenation of hydrazonoyl chlorides 
(Figure 6).27 These generated nitrile imines are able to react with a number of 
dipolarophiles, leading to various cycloaddition products.  
 
Figure 6 Generations of nitrile imine and related reactions. 
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Fluorescence Protein Labeling Strategy and Fluorogenic Probes 
Fluorescence microscopy and fluorescent labeling are powerful tools for biological 
research. Fluorescent labeling includes direct labeling with fluorophore probes and 
labeling with fluorescence turn-on probes. For the former one, an ideal fluorophore should 
have small size, intense brightness, good spectral properties and long-term photostability.28  
For the latter one, fluorogenic reactions lead to fluorescent products from two non-
fluorescent reagents. The turn-on fluorescence comes from the new fluorophore scaffold 
synthesized through cycloaddition of starting materials, or from activation of fluorescence 
resonant energy transfer (FRET) from an energy-transfer agent.29 Reactions with the 
dienophile and removal of a functional group which quenches fluorescence of a 
fluorophore may also increase inherent fluorescence signal from original probes. These 
activatable fluorescent turn-on probes are highly desirable for the rapid imaging of 
biomolecules, low background signal and simple labeling step without removal of 
unreacted reagents.29  
 However, because of the difficulty of design, only a few probes have been reported 
in recent years. Lin and co-workers firstly discovered a photo-induced tetrazole-alkene 
cycloaddition and termed it as “photoclick reaction” in 2008 (Figure 7).30  Photoclick 
reaction is biocompatible, easier to trigger, more convenient to monitor, as well as highly 
photoactivable.  Additionally, it provides spatial and temporal control over the labeling 
process. 31 Fluorescence from the photo-induced cycloaddition product was observed after 
irradiation of UV lamp at 302 nm. The fast reaction requires reactive intermediate species 
triggered by light, and can be finished in 1 min. Moreover, the facile products from facile 
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alkenes and alkynes also show the similar efficiency. In addition, when reacting with 
tetrazole, cyclic alkenes tend to have higher yields than acyclic counterpart.32 Reaction has 
been reported in the labeling of protein or peptide in vitro and in vivo.33 Recently, Guo and 
co-workers demonstrated a similar fluorogenic probe based on styrene–tetrazine 
cycloaddition for in live cell labeling.34  
 
 
 
Figure 7 “Photoclick” 1,3-dipolar cycloaddition reaction 
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Histone Deacetylases  
Introduction 
Acetylation of histones is a very important posttranslational modification (PTM) 
process in various organisms. The highly reversible acetylation process occurs at lysine 
residues on histones, especially amino-terminal tail of histones. Under catalysis of histone 
acetyltransferases (HATs), lysine residues on histones become acetylated. Histone 
acetylation affects chromatin structure and gene expression, allowing the acetylated 
chromatin more accessible to interacting proteins.35 As opposed to acetylation, histone 
deacetylation catalyzed by histone deacetylases (HDACs) removes of the acetyl group 
from an ε-N-acetyl lysine on a histone. To date, 18 HDACs have been identified. Based on 
their phylogenetic similarity, human HDACs can be classified into four subclasses:  Class 
I (HDAC1, HDAC2, HDAC3, and HDAC8), Class II (HDAC4, HDAC5, HDAC6, 
HDAC7, HDAC9, and HDAC10), Class III (SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, 
SIRT6, and SIRT7), and Class IV (HDAC11). Unlike Class I, II and IV which contains 
metal ion catalysis cofactor, Class III HDACs require NAD+ as a cofactor for deacetylation. 
Histone deacetylation has impact on chromatin structure by making the DNA wrapped by 
histone more tightly, as well as transcription, protein-protein interaction and dynamics of 
histone crosstalk. Thus, abnormal HDACs or aberrant deacetylation process contributes to 
many human diseases, including cancer and diverse disorders.  
Discovery of HDAC inhibitors is important to the cellular regulation and anti-
cancer therapeutic development. To date, FDA has approved four HDAC inhibitor drugs 
for anti-cancer purpose. At the same time, five HDAC inhibitor drugs are in clinical trial 
process. The first HDAC inhibitor drug Vorinostat, also known as suberoylanilide 
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hydroxamic acid (SAHA, Figure 8), is approved by FDA for the treatment of cutaneous 
T-cell lymphoma (CTCL) in 2006.36 The hydroxamic acid group can chelate the active-site 
zinc in HDAC and inhibit binding from other substrates. Later, Romidepsin (FK228, 
Figure 8) was approved in 2009 for its striking treatment in peripheral T-cell lymphoma 
(PTCL). It is notable that Romidepsin is a cyclicpeptide drug isolated from 
Chrossmobacterium violaceum. The intramolecular disulfide bond of Rommidepsi can be 
reduced in cells, yielding a thiol side chain that can chelate the active-site zinc in HDAC.37 
Another example is Trichostatin A (TSA, Figure 8) , a widely used HDAC inhibitor with 
30-fold stronger inhibitory activity than SAHA.38, 39 However, TSA has not been applied 
to clinical trial yet. For most of these FDA-approved drugs, a big problem is nonselectivity 
towards most HDACs, which may inhibit non-target HDAC or other non-target proteins, 
leading to side effects including cardiac arrhythmia and thrombocytopenia.40,41  
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Figure 8  Commonly used HDAC8 inhibitors 
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HDAC8 structure 
Among all HDAC homologues, HDAC8 is the best studied in both mechanism and 
structure. HDAC8 is a zinc-dependent class I deacetylase, containing 377 amino acids. It 
has been demonstrated that the overexpression of HDAC8 affects cAMP responsive 
element binding protein (CREB) phosphorylation in cells. The overexpression is also 
reported in multiple cancer tissues, including colon, breast, lung and pancreas. Substrates 
of HDAC8 include not only acetylated histones (H2A/H2B, H3 and H4 histones), but also 
some non-histone substrates. Examples of histone substrates include acetylated lysines at 
position 14 (Kac14), 16 (Kac16)  and 20 (Kac20) on histone H4 or its derivatives.42 Besides 
histone substrates, some acetylated non-histone peptides can also be catalyzed by HDAC8, 
such as arginine-Kac129 in Estrogen-Related Receptor α (ERRα), RHKK in p53, 
RSKacFE in inv(16) fusion protein, and transcription factor CREB. It has been 
demonstrated that peptides with a N-terminal arginine at the -1 position to the acetyllysine 
or a C-terminal phenylalanine at the +1 position are potential substrates of HDAC8.42 More 
non-histone substrates are being studied for specificity of deacetylation sites.  
HDAC8 is the second smallest enzyme in HDAC family. Unlike other HDACs 
catalytically active as large complexes, HDAC8 functions as a small complex and is 
therefore chosen as a good target for the study of deacetylase. 43 In general, the structure 
of HDAC8 is a head-to-head dimer, with a zinc ion and two potassium ions in each 
monomer part.44 The zinc ion is pentacoordinated by Asp178, His180, Asp267 and one or 
two water molecules.44 The monomer HDAC8 consists of eight parallel β-sheets 
surrounded by eleven α-helixes. In the active site, there is a long hydrophobic tunnel 
leading to a narrow pocket. The tunnel and the surrounding nine loops have been 
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demonstrated to accommodate the binding of acetylated substrates.  Crystal structure of 
HDAC8 and Trichostatin A (TSA), a well-studied HDAC inhibitor, illustrates how TSA 
interact with HDAC via the binding of the  tunnel and three nearby loops (Figure 9). 36 
 
 
 
 
Figure 9  Surface of HDAC8 with two TSA molecules near active site. PDB ID:1t64. The 
first TSA molecule binds to the active site inside the tunnel. The second TSA molecule 
binds to the cavity nearby.45  
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Catalytic Mechanism of HDAC8 
 Figure 10 illustrates a proposed mechanism of HDAC8. As mentioned previously, 
the Zn2+ ion has a 5-coordinate square pyramidal geometry, including two asparagines, a 
histidine and two water molecules. During the catalysis process, one of these two water 
molecules is replaced by the acetyl lysine substrate. His143 functions as a base and accepts 
a proton from the zinc-chelated water molecule. The rate-determining step is where the 
deprotonated water molecule nucleophilically attacks the chelated carbonyl oxygen from 
acetylated lysine substrates. A hydrogen bond is generated between Tyr306 and the 
carbonyl group, forming a tetrahedron oxyanion intermediate. Later, the deacetylated 
lysine product leaves after getting a proton from the protonated base. Finally, the acetate 
product leaves after replaced by a water molecule.36  To prove the key role of His143 and 
Tyr306, Christianson and co-workers mutated His143 to arginine. Additionally, Marco and 
coworkers also mutated Tyr306 to phenylalanine, respectively.46,47 Results show that both 
of the mutated enzymes are inactive to their substrates.  
 Due to the two monovalent cation (MVC) sites in HDAC8, the HDAC8 catalytic 
activity can be modulated by the concentration of cations such as  K+ and Na+. Fierke and 
co-workers investigated the two MVCs and demonstrated that the first MVC near the active 
site enhances HDAC8 catalysis, while the second MVC, which is 20 Å from the active site, 
decreases catalytic activity.48 In general, addition of low concentration of  K+ increases the 
catalysis activity (K1/2, act = 14 mM), while the high concentration decreases the catalysis 
activity (K1/2, int = 130 mM). 36 Additionally, other divalent metal ions can also enhance the 
HDAC8 activity, following the order Co2+ > Fe2+ > Zn2+ > Ni2+.49   
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Figure 10  Proposed mechanism for HDAC catalysis. 
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CHAPTER II 
THE NITRILIMINE-ALKENE CYCLOADDITION IS AN ULTRA RAPID 
CLICK REACTION* 
 
Introduction 
A recent mining of organic reactions for click labelling of proteins has 
revamped tetrazine-based inverse electron-demand Diels-Alder cycloaddition50–54 and 
cyclooctyne-based 1,3-dipolar cycloaddition.55–58 Unlike the Cu+-catalysed click 
reaction,59–61 both tetrazine- and cyclooctyne-involved cycloadditions undergo 
spontaneously in aqueous conditions, avoiding side reactions potentially induced by a 
transition metal catalyst.62 A noteworthy advantage of tetrazine-based click reaction is 
its fast reaction kinetics. A hitherto fastest reported tetrazine-transcyclooctene reaction 
has a second-order rate constant as 2.8×106 M-1s-1.63 Cyclooctyne was originally 
explored for labeling proteins with azide and recently extended to react with nitrone 
and tetrazine functionalities for click labeling of proteins.56,64,65 Cyclooctyne reacts 
rapidly with tetrazine.66 Derivatives of cyclooctyne that react with azide and nitrone 
with a second-order rate constant higher than 50 M-1s-1 have also been developed.67–69 
Another copper-free click reaction that has been recently explored for protein labeling 
but not yet highly appreciated is the nitrilimine-alkene cycloaddition.70 On contrary to 
tetrazine and cyclooctyne that stably exist in aqueous conditions, nitrilimine reacts 
*Reprinted (adapted) with permission from “The nitrilimine–alkene cycloaddition is 
an ultra rapid click reaction” by Wang, X. S., Lee, Y. -J., and Liu, W. R. Chem. 
Commun 2014, 50, 3176-3179. Copyright 2014 The Royal Society of Chemistry.  
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with water, therefore needs to be formed transiently.6 There are two general methods to 
transiently form nitrilimine in aqueous conditions. One is the photolysis of tetrazole and 
the other is the ionization of hydrozonoyl halide.70,71 Lin and coworkers have extended the 
first approach for photoclick labeling of proteins that contain the alkene functionality in 
living cells.72–74 The second approach has been recently explored to undergo fluorescent 
turn-on labeling of proteins incorporated with norbornene and acrylamide moieties.6,75,76 
Reaction kinetics of the nitrilimine-alkene cycloaddition that involved both tetrazole and 
hydrozonoyl chloride as nitrilimine precursors were previously characterized.6,73 All these 
characterizations were performed in a PBS-acetonitrile (1:1) buffer. The high concentration 
of chloride (140 mM) in PBS potentially offsets the transient formation of nitrilimine and 
consequently curbs its reaction with alkene. Here we report a comprehensive study of 
effects of pH and chloride concentrations on the nitrilimine-alkene cycloaddition reaction 
kinetics and demonstrate the nitrilimine-alkene cycloaddition is an ultra rapid click reaction 
for protein labeling at a slightly basic condition (pH 10) with no chloride.  
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Experimental Methods 
1. Kinetic Analysis 
Acrylamide was added to a solution of hydrazonoyl chloride (1 in Figure 11, 5 μM, 
2mL) in 1:1 acetonitrile-50 mM phosphate buffer at different pH and varying 
concentrations of chloride. The florescence increases at 480 nm due to the formation of 
pyrazoline product was monitored by PTI QM-40 fluorescent spectrophotometer with 320 
nm excitation. 
 
 
 
 
 
 
 
 
Figure 11 The nitrilimine-alkene reaction in the presence of chloride 
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2. Equation Derivation 
As indicted by Figure 11, when [H+] >> KH and [Cl+] >> KCl, the formation rates of 6 
and 7 and the consumption rate of 1 follow a relation defined by 𝒅[𝟏]
𝒅𝒕
=  𝒅[𝟔]
𝒅𝒕
+ 𝒅[𝟕]
𝒅𝒕
, in 
which 𝒅[𝟏]
𝒅𝒕
= 𝒌𝒄 ∙ [𝟓] ∙ [𝟒], 
𝒅[𝟕]
𝒅𝒕
= 𝒌𝒉 ∙ [𝟒] + 𝒌𝒉ᇲ ∙ [𝟑], [𝟑] = [𝟏] ∙
𝑲𝑪𝒍ᇱ
[𝑪𝒍ష]
 and [𝟒] = [𝟏] ∙
𝑲𝑯∙𝑲𝑪𝒍
[𝑯శ]∙[𝑪𝒍ష]
. Therefore the consumption rate of 1 can be defined as 𝒅[𝟏]
𝒅𝒕
= ቀ𝒌𝒄 ∙  
𝑲𝑯∙𝑲𝑪𝒍
[𝑯శ]∙[𝑪𝒍ష]
∙
[𝟓] + 𝒌𝒉 ∙  
𝑲𝑯∙𝑲𝑪𝒍
[𝑯శ]∙[𝑪𝒍ష]
+ 𝒌𝒉ᇲ ∙  
𝑲𝑪𝒍ᇱ
[𝑪𝒍ష]
ቁ ∙ [𝟏]  that can be integrated to give [𝟏] =  [𝟏]𝟎 ∙
𝒆
ି൬𝒌𝒄∙
𝑲𝑯∙𝑲𝑪𝒍
ൣ𝑯శ൧∙[𝑪𝒍ష]
∙[𝟓]ା𝒌𝒉∙
𝑲𝑯∙𝑲𝑪𝒍
ൣ𝑯శ൧∙[𝑪𝒍ష]
ା𝒌𝒉ᇱ∙
𝑲𝑪𝒍ᇲ
[𝑪𝒍ష]൰𝒕 . At anytime, [𝟔] + [𝟕] =  [𝟏]𝟎 − [𝟏]  and 
[𝟕]
[𝟔]
=
𝒌𝒉∙[𝟒]ା𝒌𝒉ᇲ∙[𝟑]
𝒌𝒄∙[𝟓]∙[𝟒]
=  
𝒌𝒉∙[𝟒]ା𝒌𝒉ᇲ∙ 
ൣ𝑯శ൧
𝑲𝑯
 ∙ [𝟒]
𝒌𝒄∙[𝟓]∙[𝟒]
=
𝒌𝒉ା𝒌𝒉ᇲ∙ 
ൣ𝑯శ൧
𝑲𝑯
 
𝒌𝒄∙[𝟓]
 that can be simplified to give [𝟔] =
𝒌𝒄∙[𝟓]
𝒌𝒄∙[𝟓]ା𝒌𝒉ା𝒌𝒉ᇱ∙
ൣ𝑯శ൧
𝑲𝑯ᇲ
∙ [𝟏]𝟎 ∙ (𝟏 − 𝒆
ି൬𝒌𝒄∙
𝑲𝑯∙𝑲𝑪𝒍
ൣ𝑯శ൧∙[𝑪𝒍ష]
∙[𝟓]ା𝒌𝒉∙
𝑲𝑯∙𝑲𝑪𝒍
ൣ𝑯శ൧∙[𝑪𝒍ష]
ା𝒌𝒉ᇱ∙
𝑲𝑪𝒍ᇲ
[𝑪𝒍ష]൰𝒕). 
 
3.  Protein Expression and Characterization 
DNA sequence of sfGFP2TAG 
Atgtagaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtgatgttaatgggcacaaattttctgtcc
gtggagagggtgaaggtgatgctacaaacggaaaactcacccttaaatttatttgcactactggaaaactacctgttccgtggcca
acacttgtcactactctgacctatggtgttcaatgcttttcccgttatccggatcacatgaaacggcatgactttttcaagagtgccat
gcccgaaggttatgtacaggaacgcactatatctttcaaagatgacgggacctacaagacgcgtgctgaagtcaagtttgaaggt
gatacccttgttaatcgtatcgagttaaagggtattgattttaaagaagatggaaacattcttggacacaaactcgagtacaactttaa
ctcacacaatgtatacatcacggcagacaaacaaaagaatggaatcaaagctaacttcaaaattcgccacaacgttgaagatggt
tccgttcaactagcagaccattatcaacaaaatactccaattggcgatggccctgtccttttaccagacaaccattacctgtcgaca
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caatctgtcctttcgaaagatcccaacgaaaagcgtgaccacatggtccttcttgagtttgtaactgctgctgggattacacatggc
atggatgagctctacaaaggatcccatcaccatcaccatcactaa (The mutated site is highlighted in red) 
sfGFPS2Acrk Expression and Purification 
The pEVOL-PylT-PrKRS was constructed as previously reported.6 Plasmid 
pEVOL-PylT-PrKRS plasmid and pET-sfGFPS2TAG were cotransformed with BL21 
(DE3) and plate on agar plate containing ampicillin (100 μg/mL) and chloramphenicol (34 
μg/mL). A single colony was picked and inoculated into 5 mL of LB medium with 
ampicillin and chloramphenicol. This overnight culture was used to inoculate 100 mL of 
LB medium. Cells were grown at 37℃ in an incubator (250 r.p.m.). When OD600, 200 mM 
Nε-acryloyl-lysine (AcrK), 1 mM IPTG and 0.2% arabinose were added. After 8 hour 
induction, cells were harvested by being centrifuged at 4000 g for 15 min, and resuspended 
in a lysis buffer (50 mM NaH2PO4, 250 mM NaCl, 10 mM imidazole, pH 8.0. The cell 
lysate was sonicated in an ice bath six times (2 min each pulse, 5 min interval for cooling), 
and centrifuged at 1000g for 60 min (4 ℃). The supernatant was isolated and incubated 
with 1 mL Ni-NTA resin (Qiagen) (1.5 h, 4 ℃), and then loaded to a column. The protein-
resin mixture was washed with 50 mL of a wash buffer containing 50 mM NaH2PO4, 250 
mM NaCl and 10 mM imidazole (pH 8.0), and eluted by a elution buffer containing 50 mM 
NaH2PO4, 250 mM NaCl and 250 mM imidazole (pH 8.0). The purified protein was 
concentrated and dialyzed into a buffer containing 10 mM ammonium bicarbonate. The 
protein was analyzed by 15% SDS-PAGE and stored at -80℃. 
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4. Protein Labeling with Hydrazonoyl Chloride 1 
pH dependence of the labeling reaction in the presence of chloride 
   Hydrazonoyl chloride 1(5 mM, 15 μL) was added to the solution of sfGFP2Acrk (5 
μM, 500 μL) in 1:1 acetonitrile-50 mM phosphate buffer with 50 mM chloride (pH 6-10) 
incubated at RT for 10 min and then quenched by 500 mM acrylamide. The labeled-protein 
was further purified using Ni-NTA resin (5 μL). The protein-bound resin was centrifuged 
(10 min, 13.4k) and washed with water for 4 times. After boiling the resin in 6X protein 
loading buffer (375 mM Tris-HCl, 10% SDS, 30% Glycerol, 0.03% Bromophenol blue, 
600 mM DTT) and filtering, the labeled protein was released and subjected to 15% SDS-
PAGE analysis. In-gel fluorescence detection was performed using BioRad ChemiDoc 
XRS+ Imaging system before the gel was stained by coomassie blue.   
Chloride dependence of the labeling reaction at pH7 
Hydrazonoyl chloride 1 (5 mM, 15 μL) was added to the solution of sfGFP2Acrk 
(5 μM, 500 μL) in 1:1 acetonitrile-50 mM phosphate buffer (pH7), with chloride 
concentration from 0 to 200 mM recpectively, incubated at RT for 30 min and then 
quenched by 500 mM acrylamide. The labeled-protein was further purified using Ni-NTA 
resin(5 μL). The protein-bound resin was centrifuged (10 min, 13.4k) and washed with 
water for 4 times. After boiling the resin in 6X protein loading buffer (375 mM Tris-HCl, 
10% SDS, 30% Glycerol, 0.03% Bromophenol blue, 600 mM DTT) and filtering, the 
labeled protein was released subjected to 15% SDS-PAGE analysis. In-gel fluorescence 
detection was performed using BioRad ChemiDoc XRS+ Imaging system before the gel 
was stained by coomassie blue. 
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The labeling reaction at pH 10 without chloride 
Hydrazonoyl chloride 1 (5 mM, 15 μL) was added to the solution of sfGFP2Acrk 
(5 μM, 500 μL) in a 1:1 acetonitrile-50mM phosphate buffer (pH10 without chloride), 
incubated at for 1, 2, 3, 4 min respectively and then quenched by 500 mM acrylamide. The 
labeled-protein was further purified using Ni-NTA resin(5 μL). The protein-bound resin 
was centrifuged (10 min, 13.4k) and washed with water for 4 times. After boiling the resin 
in 6X protein loading buffer (375 mM Tris-HCl, 10% SDS, 30% Glycerol, 0.03% 
Bromophenol blue, 600 mM DTT) and filtering, the labeled protein was released and 
subjected to 15% SDS-PAGE analysis. In-gel fluorescence detection was performed using 
BioRad ChemiDoc XRS+ Imaging system before the gel was stained by coomassie blue. 
Labelling with different proteins 
Hydrazonoyl chloride 1 (5 mM, 15 μL) was added to different solutions: 1: 
sfGFP2AcrK; 2: sfGFP-p53 peptide fusion; 3: BSA; 4: lysozyme; 5: sfGFP; 6: sfGFP ( all 
proteins are 5 μM, 500 μL) in a 1:1 acetonitrile-50mM phosphate buffer (pH10 without 
chloride), incubated at for 1, 2, 3, 4 min respectively and then quenched by 500 mM 
acrylamide. The labeled-protein was further purified using Ni-NTA resin (5 μL). The 
protein-bound resin was centrifuged (10 min, 13.4k) and washed with water for 4 times. 
After boiling the resin in 6X protein loading buffer (375 mM Tris-HCl, 10% SDS, 30% 
Glycerol, 0.03% Bromophenol blue, 600 mM DTT) and filtering, the labeled protein was 
released and subjected to 15% SDS-PAGE analysis. In-gel fluorescence detection was 
performed using BioRad ChemiDoc XRS+ Imaging system before the gel was stained by 
coomassie blue. 
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Figure 12 The selective labeling of sfGFP2AcrK with diarylnitrilimine. Proteins (1: 
sfGFP2AcrK; 2: sfGFP-p53 peptide fusion; 3: BSA; 4: lysozyme; 5: sfGFP; 6: sfGFP 
incorporated with a meta-trifloromethyl-phenylalanine at its S2 site) were incubated with 
5 mM hydrazonyl chloride 1 for 20 min before they were analyzed by SDS-PAGE. The 
top panel shows the Coomassie-blue staining of the gel and the bottom panel shows the 
fluorescent imaging of the gel before it was Coomassie-blue stained. The data clearly 
demonstrated the specific reaction between acrylamide and nitrilimine. 
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Results and Discussion 
We chose a hydrozonoyl chloride (1 in Figure 13) as a nitrilimine precursor for our 
kinetic analysis due to the difficulty of quantitative photolysis of a tetrazole to form a 
nitrilimine that nonetheless reacts with water and chloride in aqueous conditions to form a 
hydrozonoyl chloride. In an aqueous buffer with a high concentration of chloride ion, 1 
presumably undergoes two parallel two-step ionization processes to lose a proton cation 
and a chloride anion to generate a nitrilimine 4 as shown in Figure 13. 4 then reacts either 
with 5 to form a fluorescent cycloaddition product 6 or with water to produce a hydrazide 
7. 7 can also be made from the reaction of water with the immediate dechlorination product 
3 of 1. These two parallel ionization processes of hydrozonoyl halide in aqueous conditions 
were studied and demonstrated previously.77 Assuming the ionization of 1 to form 4 is a 
fast equilibrium, the formation of 6 will follow  
[𝟔] = 𝒌𝒄∙[𝟓]
𝒌𝒄∙[𝟓]ା𝒌𝒉ା𝒌𝒉ᇱ∙
ൣ𝑯శ൧
𝑲𝑯ᇲ
∙ [𝟏]𝟎 ∙ (𝟏 − 𝒆
ି൬𝒌𝒄∙
𝑲𝑯∙𝑲𝑪𝒍
ൣ𝑯శ൧∙[𝑪𝒍ష]
∙[𝟓]ା𝒌𝒉∙
𝑲𝑯∙𝑲𝑪𝒍
ൣ𝑯శ൧∙[𝑪𝒍ష]
ା𝒌𝒉ᇱ∙
𝑲𝑪𝒍ᇲ
[𝑪𝒍ష]൰𝒕)                   (1) 
when 5 is excessive, [H+]>>KH, and [Cl-]>>KCl. In eqn (1), [1]0 represents the initial 
concentration of 1. Based on eqn (1), the pseudo first-order reaction rate constant of the 6 
formation can be described as  
𝒌𝒂𝒑𝒑 = 𝒌𝒄 ∙
𝑲𝑯∙𝑲𝑪𝒍
[𝑯శ]∙[𝑪𝒍ష]
∙ [𝟓] + 𝒌𝒉 ∙
𝑲𝑯∙𝑲𝑪𝒍
[𝑯శ]∙[𝑪𝒍ష]
+ 𝒌𝒉′ ∙
𝑲𝑪𝒍ᇱ
[𝑪𝒍ష]
.                     (2) 
This equation can be further simplified as  
𝒌𝒂𝒑𝒑 = 𝒌𝒄(𝒐𝒃𝒔) ∙ [𝟓] + 𝒌𝒉(𝒐𝒃𝒔)                                           (3) 
Where 
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𝒌𝒄(𝒐𝒃𝒔) = 𝒌𝒄 ∙
𝑲𝑯∙𝑲𝑪𝒍
[𝑯శ]∙[𝑪𝒍ష]
.        (4) 
As 6 is highly fluorescent, its formation can be facilely detected using a fluorescent 
spectrophotometer and analysed to obtain kapp. The determined kapp values at varied 
concentrations of 5, at a given pH and a chloride concentration can be readily fitted to eqn 
(3) to obtain kc(obs). In principle, the determined kc(obs) values at varying pH and chloride 
concentrations will allow to assess kc, the second-order rate constant of the nitrilimine-
alkene cycloaddition in aqueous conditions.  
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Figure 13 The ionization of diarylhydrozonoyl chloride to form diarylnitrilimine in 
aqueous conditions with chloride and the subsequent reactions with alkene and water. 
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We first studied the pH dependence of kc(obs) at 50 mM chloride. Reactions 
between 5 M 1 and varying concentrations of acrylamide at five given pH (6-10) were 
monitored using a PTI QM-40 fluorescent spectrophotometer with an excitation light 
at 320 nm and an emission detection at 480 nm. The fluorescence incremental data 
were fitted to a single exponential increase equation to obtain kapp. The resolved kapp 
values were then plotted against the acrylamide concentrations. As shown in Figure 
14, kapp is linearly dependent on the acrylamide concentration at a given pH and the 
data were readily used to determine kc(obs), validating the mechanism proposed in 
Figure 13. Although log (kc(obs)) shows a linear dependence on pH (Figure 14A) as 
eq. (4) predicts, (eq. (4) can be transformed as 𝒍𝒐𝒈൫𝒌𝒄(𝒐𝒃𝒔)൯ = 𝒍𝒐𝒈 ቀ
𝒌𝒄∙𝑲𝑯∙𝑲𝑪𝒍
[𝑪𝒍ష]
ቁ + 𝒑𝑯), 
the data can not be simply fitted to eqn (4) and best fitted to  
𝒌𝒄(𝒐𝒃𝒔) = 𝒌𝒄 ∙
(𝑲𝑯)𝒙∙𝑲𝑪𝒍
[𝑯శ]𝒙∙[𝑪𝒍ష]
     (5) 
with an x value as 0.64±0.01 and 𝒌𝒄 ∙
(𝑲𝑯)𝟎.𝟔𝟒∙𝑲𝑪𝒍
[𝑪𝒍ష]
 as (1.42±0.01) ×10-5. Any deviation 
from eq. (4) may be due to the presence of chloride that changes the proton activity 
during the ionization process. This is highly possible as a similar deviation was not 
observed during the kinetic analyses in reaction conditions without chloride, which 
will be presented later. Figure 14A clearly shows that the observed cycloaddition rate 
constant increased about 200 folds when pH was changed from 6 to 10. Therefore, 
when an acrylamide-containing protein is separately labeled with 1 at different pH, 
faster labeling rates are expected at higher pH values. To approve this, we performed 
the labeling of sfGFP2AcrK (a superfolder green fluorescent protein with Nε-acryloyl-
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lysine (AcrK) incorporated at its S2 position) by 150μM 1 for 15 min at 50 mM 
chloride and pH from 6 to 10. AcrK is a noncanonical amino acid with an acrylamide 
moiety that can be genetically incorporated into proteins at amber mutations sites in E. 
coli using an evolved pyrrolysyl-tRNA synthetase-𝐭𝐑𝐍𝐀𝐂𝐔𝐀
𝐏𝐲𝐥  pair. The expression of 
sfGFP2AcrK followed a method described in a previous publication.6 Presented in 
Figure 14B, the labeling efficiency is clearly pH dependent, with higher pH leading 
to more efficient labeling.  
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Figure 14  (A) the pH dependence of kc(obs). The inset shows the acrylamide 
concentration dependence of kapp at pH 8 and 50 mM chloride in acetonitrile-50 mM 
phosphate buffer (1:1). (B) The labeling efficiency of sfGFP2AcrK by 1 at different pH. 
The labeling reactions between 5 μM sfGFP2AcrK and 150 μM 1 were carried out in 
acetonitrile-50mM phosphate buffer (1:1) for 15 min before 500 mM acrylamide was 
added to sequestrate 1 from reacting with sfGFP2AcrK and then the labeling solutions were 
analyzed by SDS-PAGE. The top panel shows the Coomassie blue stained gel and the 
bottom panel presents a fluorescent image of the same gel before it was stained by 
Coomassie blue. The fluorescent imaging was performed with a BioRad ChemDoc XRS 
system under UV irradiation. 
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Eqn (5) also indicates an inverse linear dependence of kapp on the chloride 
concentration, which has been approved by our kinetic studies performed in varying 
chloride concentrations and pH 9. At a particular chloride concentration (10-100 mM), 
the determined kapp values are linearly dependent on the acrylamide concentrations, 
which were used to obtain kc(obs). Plotting kc(obs) against 1/[Cl-] shows that this 
dependence is linear (Figure 15 A). We also did similar kinetic analyses at 1 mM 
chloride. Although the determined kapp values are much higher than those determined 
at higher chloride concentrations, the kapp values at different acrylamide concentrations 
are almost constant, and therefore not valid for the calculation of kc(obs). It is possible 
that at a low chloride concentration, the two dechlorination processes (2 to 4 and 1 to 
3) do not reach fast equilibria, invalidating Figure 13 and eqn (1) in data analysis. This 
study clearly shows a strong inhibitory effect of chloride on the nitrilimine-alkene 
cycloaddition, indicating that applying the nitrilimine-alkene cycloaddition for protein 
labeling needs to avoid running the reaction at a high chloride concentration. This is 
exactly what we observed in the labeling reactions of sfGFP2AcrK by 1 at pH 7 and 
different chloride concentrations (Figure 15B). A 30 min labeling reaction in the 
absence of chloride led to an intensely fluorescently labeled protein. The labeling 
efficiency gradually diminished when the chloride concentration was increased from 
0 to 200 mM.  
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Figure 15  (A) the chloride dependence of kc(obs). (B) The labeling efficiency of 
sfGFP2AcrK by 1 at pH 7 and different chloride concentrations. The labeling reactions 
between 5 μM sfGFP2AcrK and 150 μM 1 were carried out in acetonitrile-50mM 
phosphate buffer (1:1), pH 7, and varying chloride concentrations for 30 min before 500 
mM acrylamide was added to sequestrate 1 from reacting with sfGFP2AcrK and then the 
labeling solutions were analyzed by SDS-PAGE. The top panel shows the Coomassie blue 
stained gel and the bottom panel presents a fluorescent image of the same gel before it was 
stained by Coomassie blue. 
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The aforementioned kinetic analyses at 1 mM chloride prompted us to look into 
the reaction kinetics of the nitrilimine-alkene cycloaddition in the absence of chloride. 
Without chloride, the ionization of 1 and subsequent reactions with water and alkene 
will presumably follow a mechanism presented in Figure 16. The two dechlorination 
steps become rate limiting. Since the ionization of 1 will generate an equal amount of 
chloride in reaction conditions, providing 1 at a concentration much lower than 1 mM 
will not eviscerate the mechanism shown in Figure 16. Figure 16 depicts the  
formation of 6 following  
[𝟔] = 𝒌𝒄∙[𝟓]
𝒌𝒄∙[𝟓]ା𝒌𝒉ା𝒌𝒉ᇱ∙
ൣ𝑯శ൧
𝑲𝑯ᇲ
∙ [𝟏]𝟎 ∙ (𝟏 − 𝒆
ି൬𝒌𝑪𝒍∙
𝑲𝑯
ൣ𝑯శ൧
ା𝒌𝑪𝒍ᇱ൰𝒕)   (6) 
that results in an apparent rate constant defined as  
𝒌𝒂𝒑𝒑 = 𝒌𝑪𝒍 ∙
𝑲𝑯
[𝑯శ]
+ 𝒌𝑪𝒍′.     (7) 
Eqn (7) shows that kapp is inversely proportional to the proton centration but not related 
to the provided acrylamide, which was observed during kinetic analyses of the 
nitrilimine-alkene cycloaddition in the absence of chloride. When reactions between 5 
μM 1 and different acrylamide concentrations were performed at a specific pH without 
chloride, they all resulted in a same reaction rate constant (inset of Figure 17A). 
Raising the pH value led to higher reaction rate constants. The logarithms of 
determined kapp values as a function of pH are presented in Figure 17A, which can be 
well fitted to eqn (7). At pH 10 with chloride, the determined kapp is 0.111±0.002 s-1. 
Since this rate constant is not related to the concentrations of both 1 and the acrylamide, 
so using 1 to label a protein with an acrylamide moiety at any concentrations of 1 and 
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the protein will have a labeling half life close to 6 s when the chloride anion is absent 
in labeling conditions, further resulting in almost instantaneous protein labeling. To 
demonstrate this rapid labeling process, we tested the labeling of sfGFP2AcrK by 1 at 
pH 10 for different lapses of time. As shown in Figure 17B, labeling sfGFP2AcrK 
with 1 for 1 min to 4 min all led to an intensely fluorescently labeled protein with an 
equally fluorescent intensity, implying that the labeling reaction was mostly completed 
within 1 min.  
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Figure 16 The ionization of diarylhydrozonoyl chloride to form diarylnitrilimine in 
aqueous conditions without chloride and the subsequent reactions with alkene and water. 
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Figure 17 (A) the pH dependence of kapp in the absence of chloride. The data were 
fitted to eqn (7). The inset shows the acrylamide concentration dependence of kapp at pH 5-
10 in acetonitrile-50 mM phosphate buffer (1:1) but absence of chloride. All determined 
kapp values at a given pH are similar. (B) The labeling efficiency of sfGFP2AcrK by 1 at 
pH 10 without chloride. The labeling reactions between 5 μM sfGFP2AcrK and 150  μM 1 
were carried out in acetonitrile-50mM phosphate buffer (1:1) with no chloride provided for 
different lapses of time (1-4 min) before 500 mM acrylamide was added to sequestrate 1 
from reacting with sfGFP2AcrK and then the labeling solutions were analyzed by SDS-
PAGE. The top panel shows the Coomassie blue stained gel and the bottom panel presents 
a fluorescent image of the same gel before it was stained by Coomassie blue.  
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Conclusions 
Being a catalyst-free click reaction type, nitrilimine-alkene cycloaddition has been 
explored for click and photo-click labeling of proteins. All previous kinetic 
characterizations of the nitrilimine-alkene cycloaddition were completed in PBS buffers 
that contained high concentrations of chloride. The current study clearly shows that all 
previously measured second-order rate constants of the nitrilimine-alkene cycloaddition 
are apparent second-order rate constants that are significantly influenced by pH and 
chloride concentrations. Based on eqn (5), one would need to determine KH and KCl to 
calculate kc, the second-order rate constant of the nitrilimine-alkene cycloaddition. When 
we derived eqn (1), we applied the following preconditions; [H+] >> KH and [Cl-] >> KCl. 
When these conditions do not hold, the determined apparent rate constant in theory will in 
theory follow  
𝒌𝒄(𝒐𝒃𝒔) = 𝒌𝒄 ∙
𝑲𝑯∙𝑲𝑪𝒍
([𝑯శ]ା𝑲𝑯)∙([𝑪𝒍ష]ା𝑲𝑪𝒍)
    (8) 
but should be best described as  
𝒌𝒄(𝒐𝒃𝒔) = 𝒌𝒄 ∙
(𝑲𝑯)𝟎.𝟔𝟒∙𝑲𝑪𝒍
([𝑯శ]ା𝑲𝑯)𝟎.𝟔𝟒∙([𝑪𝒍ష]ା𝑲𝑪𝒍)
    (9) 
due to the proton activity deviation from what is indicated by the pH. As indicated by eqn 
(9), in a specific chloride concentration, kc(obs) will reach a plateau when [H+] << KH. As 
we did not observe the trend of kc(obs) becoming saturated to pH 10, a safe guess of a KH 
value is small than 10-12. Similarly, kc(obs) showed an inversely proportional dependence of 
the chloride concentration when lower than 10 mM. A safe estimate of a KCl value is small 
than 10-3. We have determined that at 50 mM chloride, 𝒌𝒄 ∙
(𝑲𝑯)𝟎.𝟔𝟒∙𝑲𝑪𝒍
[𝑪𝒍ష]
 is 1.42×10-5. With 
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two estimated values of KH and KCl, we can easily determine a kc value higher than 3.4×104 
M-1s-1. This reaction rate constant is comparable to that of the rapid transcyclooctene-
tetrazine cycloaddition and makes the nitrilimine-alkene cycloaddition one of the fastest 
click reactions. Another implication of our study is the possibility of different labeling 
kinetics in extracellular and intracellular spaces when the nitrilimine–alkene reaction is 
applied for in vivo labeling. Mammalian cells maintain an intracellular chloride 
concentration which is much lower than their extracellular environments.78 This large 
chloride concentration variation may allow for the application of the nitrilimine–alkene 
reaction to specifically achieve intracellular protein sensitization. 
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CHAPTER III 
PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARIES FOR THE 
IDENTIFICATION OF INHIBITORS OF HISTONE DEACETYLASES 
 
Introduction 
 Histone deacetylases (HDAC8) comprise an indispensable enzyme class for 
humans. Aberrant overexpression of HDACs has been demonstrated to be related with 
many human diseases such as cancers. Thus, discovery of HDAC inhibitors are very import 
to therapeutic studies. Current widely used HDAC inhibitors includes vorinostat (SAHA), 
trichostatin A (TSA), and Romidepsin (FK228). Although these inhibitors have shown 
excellent inhibition ability through chelation of metal ion at active site, selective inhibition 
is a drawback due to non-specificity to most HDACs. 
To investigated more potential HDAC inhibitors with high affinity and specificity, 
focus has been raised on peptide-based molecules. Due to advantages such as high binding 
affinity, cell permeability, less toxicity, high target specificity, peptide-based molecules 
have emerged as indispensable leads for drug discovery. Moreover, development of solid-
phase peptide synthesis (SPPS) makes peptide-based molecules synthesized efficiently and 
conveniently.79 Amongst these peptide drugs, cyclic peptides are very attractive. Compared 
to linear counterparts, cyclic peptides have dominant advantages including conformational 
rigidity and stability against proteolysis.  
Recent years have seen numerous reports on the construction of cyclic peptide 
libraries. Amongst these methodologies, phage display is a highly powerful tool in high-
throughput screening of enzyme inhibitors. Phage display expresses foreign peptides on 
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the surface of filamentous phages. By linking phenotype to genotype, phage display can be 
used to build peptide library from the construction of phage library in DNA level. The ease 
of genetic manipulation makes phage display an outstanding biological platform. However, 
one pitfall of the phage-displayed peptide library is the limitation of 20 canonical amino 
acids.  To overcome this shortage, one strategy is using chemoselective bioconjugation and 
surface chemistry techniques. Another strategy is to incorporate non-canonical amino acids 
which can efficiently expand chemical diversity as well as provide more strategies of 
cyclization. Compared to bioconjugation methodologies which require the installation of 
biorthogonal reagents, the incorporation of NCAA is more straightforward and easily 
manipulated. 
The thiol group on cysteine is very reactive and undergoes a wide variety of 
reactions, such as Michael addition and nucleophilic substitution. To generate a cyclic 
peptide, many researchers have focused on bis-cysteine cyclic peptides [11]. The most well-
studied approach of the cyclization was through an intramolecular disulfide bridge between 
two internal cysteine thiol groups. O’neil and co-workers firstly reported phage-displayed 
cyclic peptide library consists of two cysteines and six randomized amino acids in 
between.80 High-affinity cyclic peptides with disulfide bonds are selected as inhibitors of 
platelet glycoprotein IIb/IIIa.80,81 However, the disulfide bond is reducible, and therefore 
its application in vivo is limited. To overcome the limitation of disulfide bonds, we 
explored reactions using a cysteine with other functional groups instead of a reaction 
between two cysteines. To expand the chemical diversity of cyclic peptides, we used a non-
canonical amino acid (NCAA), rather than any canonical amino acid, as a cyclization 
reagent. The incorporation of NCAA into a peptide is based on stop codon suppression. In 
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this approach, a nonsense stop codon (such as UAG) is used to direct the incorporation of 
NCAAs when a particular NCAA-corresponding aminoacyl-tRNA synthetase (aaRS)-
tRNA pair is present in cells. 
In this dissertation the well-studied 1,4-addition between cysteine and the 
acrylamide moiety is used as cyclization approach (Figure 18). The second order rate 
constant of the reaction between acrylamide and β-mercaptoethanol (β-ME) is 0.013 ± 
0.001 M−1 s−1 at pH 7.4[11]. Our group recently synthesized two acrylamide-containing 
NCAAs, Nε-acryloyl-L-lysine (AcrK) and Nε-crotonyl-L-lysine (CrtK), and incorporated 
them into proteins at amber mutation sites. Then the reaction between AcrK and β-ME was 
investigated. Results show that in a slightly alkali environment (pH~8), both proteins 
bearing these NCAAs can be labeled with β-ME efficiently6. Hereby we used this efficient 
1,4-cycloaddition for the construction of phage-displayed cyclic peptide library.  
 
 
 
 
Figure 18  1,4–addition between cysteine and the acrylamide moiety 
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Experimental Methods 
1. Synthesis of NCAAs 
Synthesis of Nε-acryloyl-L-lysine (AcrK)6 
To a solution of N-hydroxysuccinimide (1.3 g, 11.3 mmol) in anhydrous 
dichloromethane (25 mL) was added N,N-diisopropylethylamine (1.5 mL, 8.9 mmol), 
followed by dropwise addition of acryloyl chloride (0.8 mL, 9.3 mmol) in ice bath over 10 
min. The mixture was then stirred for 10 hours at room temperature. The mixture was 
extracted with ethyl acetate (50 mL), washed with saturated NH4Cl solution and brine, and 
dried with anhydrous sodium sulfate. The solution was filtered and evaporated under 
vacuum to give 2 (1.5 g) as yellow oil.  
To a solution of copper(II) sulfate pentahydrate (1.0 g, 4.0 mmol) in water (50 mL) 
was added lysine hydrochloride (1.5g, 8.0 mmol) and sodium bicarbonate (1.9g, 22.4 
mmol). The mixture was stirred at room temperature for 20 min. A solution of compound 
2 in acetone (20 mL) was added to the reaction. The reaction mixture continued stirring at 
room temperature for additional 10 h. The blue mixture was filtered, and the blue filter 
cake was washed with water (three times) and acetone, dissolved in a solution of water and 
chloroform (v/v = 1:1, 100 mL), stirred at room temperature for 20 min. To the suspension 
was added 8-hydroxyquinoline (1.6 g, 11.0 mmol). The solution was stirred at room 
temperature for 30 min. The green suspension was filtered, and the filtrate was washed 
with chloroform for three times, concentrated under reduced pressure, subjected to ion-
exchange chromatography for further purification, and give Nε-acryloyl-L-lysine as a white 
powder (1.2 g, 60%).  
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Figure 19 Synthesis of AcrK. 
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Synthesis of  Nε-crotonyl-L-lysine (CrtK)6  
A suspension of Boc-Lys(Cbz)-OMe (4.00 g, 10.1 mmol) and palladium on carbon 
(10% Pd, 0.67g, 0.64 mmol) was stirred under a hydrogen balloon at roomt temperature 
for 3 h. The mixture was filtered over a celite pad, and the filtrate was concentrated to give 
4 (2.51 g) as a clear oil. The product is pure enough for the next step.  
To a solution of 4 (2.51 g, 9.6 mmol) and crotonic acid (1.70g, 19.2 mmol) in 
anhydrous dichloromethane (50 mL) was added dimmethylaminolpyridine (0.048 g, 3.8 
mmol), followed by dropwise addition of 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (2.3 g, 12 mmol) in anhydrous dichloromethane (10 mL) over 10 min.The 
mixture was stirred at room temperature for 15 h, extracted by ethyl acetate (50 mL), 
washed with brine (50 mL x 3), dried with anhydrous MgSO4, evaporated and subjected to 
chromatography to afford 5 (2.66 g) as a clear oil for next step without further purification. 
To a solution of 5 (2.66 g, 8.0 mmol) in tetrahydrofuran (25 mL) was added lithium 
hydroxide solution (1 M, 40 mL, 40 mmol) in an ice-water bath. The reaction was stirred 
in the ice-water bath for 2 h. The reaction mixture was diluted with water (25 mL), 
extracted with ethyl acetate (25 mL x 3) to remove impurities. The aqueous layer was 
adjusted to pH 3 with 6 M hydrochloric acid solution and extracted with ethyl acetate (25 
mL x 2). The combined ethyl acetate solution was washed with brine (25 mL x 3), dried 
with anhydrous MgSO4, concentrated under reduced pressure to afford a colorless oil for 
next step without further purification.  
To a solution of hydrochloric acid in dioxane (4 M, 10 mL, 40 mmol) was added 
the oil from previous step. The reaction was stirred at room temperature for 4 h, diluted 
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with dichloromethane and evaporated under reduced pressure to give 6 (1.35g, 70% for 
three steps) as a white powder.  
 
 
 
 
 
 
Figure 20 Synthesis of CrtK 
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2. sfGFP mutant Expression, Purification and Labeling 
DNA sequence of Met-Ala-(Ala)5-TAG-sfGFP 
atggccgccgccgccgccgcctagaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtgatgttaat
gggcacaaattttctgtccgtggagagggtgaaggtgatgctacaaacggaaaactcacccttaaatttatttgcactactggaaa
actacctgttccgtggccaacacttgtcactactctgacctatggtgttcaatgcttttcccgttatccggatcacatgaaacggcatg
actttttcaagagtgccatgcccgaaggttatgtacaggaacgcactatatctttcaaagatgacgggacctacaagacgcgtgct
gaagtcaagtttgaaggtgatacccttgttaatcgtatcgagttaaagggtattgattttaaagaagatggaaacattcttggacaca
aactcgagtacaactttaactcacacaatgtatacatcacggcagacaaacaaaagaatggaatcaaagctaacttcaaaattcgc
cacaacgttgaagatggttccgttcaactagcagaccattatcaacaaaatactccaattggcgatggccctgtccttttaccagac
aaccattacctgtcgacacaatctgtcctttcgaaagatcccaacgaaaagcgtgaccacatggtccttcttgagtttgtaactgctg
ctgggattacacatggcatggatgagctctacaaaggatcccatcaccatcaccatcactaa (mutated sites are 
highlighted in red) 
DNA sequence of Met-Cys-(Ala)5-TAG-sfGFP 
atgtgcgccgccgccgccgcctagaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtgatgttaat
gggcacaaattttctgtccgtggagagggtgaaggtgatgctacaaacggaaaactcacccttaaatttatttgcactactggaaa
actacctgttccgtggccaacacttgtcactactctgacctatggtgttcaatgcttttcccgttatccggatcacatgaaacggcatg
actttttcaagagtgccatgcccgaaggttatgtacaggaacgcactatatctttcaaagatgacgggacctacaagacgcgtgct
gaagtcaagtttgaaggtgatacccttgttaatcgtatcgagttaaagggtattgattttaaagaagatggaaacattcttggacaca
aactcgagtacaactttaactcacacaatgtatacatcacggcagacaaacaaaagaatggaatcaaagctaacttcaaaattcgc
cacaacgttgaagatggttccgttcaactagcagaccattatcaacaaaatactccaattggcgatggccctgtccttttaccagac
aaccattacctgtcgacacaatctgtcctttcgaaagatcccaacgaaaagcgtgaccacatggtccttcttgagtttgtaactgctg
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ctgggattacacatggcatggatgagctctacaaaggatcccatcaccatcaccatcactaa (mutated sites are 
highlighted in red) 
sfGFP Derivatives Expression and Purification 
Plasmid pEVOL-PylT-PrKRS and pEVOL-PylT-BuKRS were constructed as 
previously reported.6 pEVOL-PylT-PrKRS plasmid and pET-Met-Cys-(Ala)5-TAG-sfGFP 
or pET-Met-Ala-(Ala)5-TAG-sfGFP were cotransformed with BL21 (DE3) and plate on 
agar plate containing ampicillin (100 μg/mL) and chloramphenicol (34 μg/mL). A single 
colony was picked and inoculated into 5 mL of LB medium with ampicillin and 
chloramphenicol. This overnight culture was used to inoculate 100 mL of LB medium. 
Cells were grown at 37℃ in an incubator (250 r.p.m.). When OD600, 200 mM AcrK or 
CrtK, 1 mM IPTG and 0.2% arabinose were added. After 8-hour induction, cells were 
harvested by being centrifuged at 4000 g for 15 min and resuspended in a lysis buffer (50 
mM NaH2PO4, 250 mM NaCl, 10 mM imidazole, pH 8.0. The cell lysate was sonicated in 
an ice bath six times (2 min each pulse, 5 min interval for cooling), and centrifuged at 
1000g for 60 min (4 ℃). The supernatant was isolated and incubated with 1 mL Ni-NTA 
resin (Qiagen) (1.5 h, 4 ℃), and then loaded to a column. The protein-resin mixture was 
washed with 50 mL of a wash buffer containing 50 mM NaH2PO4, 250 mM NaCl and 10 
mM imidazole (pH 8.0), and eluted by a elution buffer containing 50 mM NaH2PO4, 250 
mM NaCl and 250 mM imidazole (pH 8.0). The purified protein was concentrated and 
dialyzed into a buffer containing 10 mM ammonium bicarbonate. The protein was analyzed 
by 15% SDS-PAGE and stored at -80℃. 
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Protein Labeling with Hydrazonoyl Chloride 1 
   Hydrazonoyl chloride 1 (5 mM, 15 μL) was added to four different solutions of 
Met-Cys-(Ala)5-AcrK-sfGFP, Met-Ala-(Ala)5-AcrK-sfGFP, Met-Cys-(Ala)5-CrtK-sfGFP 
and Met-Ala-(Ala)5-CrtK-sfGFP after (5 μM, 500 μL) in a 1:1 acetonitrile-50mM 
phosphate buffer (pH10 without chloride), incubated at for 10 min respectively and then 
quenched by 500 mM acrylamide. The labeled-protein was further purified using Ni-NTA 
resin(5 μL). The protein-bound resin was centrifuged (10 min, 13.4k) and washed with 
water for 4 times. After boiling the resin in 6X protein loading buffer (375 mM Tris-HCl, 
10% SDS, 30% Glycerol, 0.03% Bromophenol blue, 600 mM DTT) and filtering, the 
labeled protein was released and subjected to 15% SDS-PAGE analysis. In-gel 
fluorescence detection was performed using BioRad ChemiDoc XRS+ Imaging system 
before the gel was stained by Coomassie blue. 
 
3. Target Protein Expression and Purification 
Protein Sequence of HDAC8 
meepeepadsgqslvpvyiyspeyvsmcdslakipkrasmvhslieayalhkqmrivkpkvasmeematfhtdaylqh
lqkvsqegdddhpdsieyglgydcpategifdyaaaiggatitaaqclidgmckvainwsggwhhakkdeasgfcylnda
vlgilrlrrkferilyvdldlhhgdgvedafsftskvmtvslhkfspgffpgtgdvsdvglgkgryysvnvpiqdgiqdekyy
qicesvlkevyqafnpkavvlqlgadtiagdpmcsfnmtpvgigkclkyilqwqlatlilggggynlantarcwtyltgvilg
ktlsseipdhefftaygpdyvleitpscrpdrnephriqqilnyikgnlkhvlenlyfqgdydipttlehhhhhh 
HDAC8 Expression and Purification  
Plasmid pHD4-HDAC8-TEV-His6 was transformed with BL21-CodonPlus(DE3). 
A single colony was picked and inoculated into 5 mL of 2xYL supplemented with 
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ampicillin (Amp) (100 μg/mL). This overnight culture was used to inoculate 500 mL of 
autioinduction TB medium (24 g/L yeast extract, 12 g/L tryptone, 8 g/L tris, 4 g/L lactose, 
1 g/L glycerol, pH 7.5) supplemented with ampicilin (100 μg/mL) and 200 μM ZnSO4. 
Cells were grown at 37℃ in an incubator (250 r.p.m.). After 20-hour auto-induction, cells 
were harvested by being centrifuged at 4000 g for 15 min, and resuspended in a lysis buffer 
(50 mM NaH2PO4, 250 mM NaCl, 10 mM imidazole, pH 8.0. The cell lysate was sonicated 
in an ice bath six times (3 min each pulse, 6 min interval for cooling), and centrifuged at 
1000g for 60 min (4 ℃). The supernatant was isolated and incubated with 1 mL Ni-NTA 
resin (Qiagen) (1.5 h, 4 ℃), and then loaded to a column. The protein-resin mixture was 
washed with 50 mL of a wash buffer containing 50 mM NaH2PO4, 250 mM NaCl and 10 
mM imidazole (pH 8.0), and eluted by a elution buffer containing 50 mM NaH2PO4, 250 
mM NaCl and 250 mM imidazole (pH 8.0). Eluted fractions were collected, concentrated 
and subjected to a Q Sepharose column (GE Healthcare) for further purification. The 
purified protein was dialyzed into a dialysis buffer (25 mM Tris - HCl, 300 mM NaCl, 200 
μM ZnSO4, 5 μM KCl, pH7.5). The protein was stored as 5 μM aliquots at -80℃.  
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Figure 21 15% SDS Page gel imaging of purified HDAC8. 
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TEV Protease Expression and Purification  
BL21(DE3) transformed with N-terminal His-tagged TEV protease was grown in 
5 mL of LB medium at 37oC. This overnight culture was used to inoculate 500 mL of 2xYT 
medium supplemented with ampicilin (100 μg/mL). Cells were grown at 37℃ in an 
incubator (250 r.p.m.) and induced with 800 μM IPTG after OD600 reached 0.4 ~ 0.6. After 
4 hour induction, cells were harvested by being centrifuged at 4000 g for 15 min, and 
resuspended in a lysis buffer (50 mM NaH2PO4, 250 mM NaCl, 10 mM imidazole, pH 8.0. 
The cell lysate was sonicated in an ice bath six times (2 min each pulse, 5 min interval for 
cooling), and centrifuged at 1000g for 60 min (4 ℃). The supernatant was isolated and 
incubated with 1 mL Ni-NTA resin (Qiagen) (1.5 h, 4 ℃), and then loaded to a column. 
The protein-resin mixture was washed with 50 mL of a wash buffer containing 50 mM 
NaH2PO4, 250 mM NaCl and 10 mM imidazole (pH 8.0), and eluted by a elution buffer 
containing 50 mM NaH2PO4, 250 mM NaCl and 250 mM imidazole (pH 8.0). The purified 
protein was concentrated and dialyzed into a buffer containing 10 mM ammonium 
bicarbonate. The protein was analyzed by 15% SDS-PAGE and stored at -80℃. 
  
4. Construction of Phage Library 
DNA sequencing of pADLg3-TGC-(NNK)6-TAG phagemid 
gcacttttcggggaaatgtgcgcggaacccctatttgtttatttttctaaatacattcaaatatgtatccgctcatgagacaataaccct
gataaatgcttcaataatattgaaaaaggaagagtatgagtattcaacatttccgtgtcgcccttattcccttttttgcggcattttgcct
tcctgtttttgctcacccagaaacgctggtgaaagtaaaagatgctgaagatcagttgggtgcacgagtgggttacatcgaactgg
atctcaacagcggtaagatccttgagagttttcgccccgaagaacgttttccaatgatgagcacttttaaagttctgctatgtggcgc
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ggtattatcccgtattgacgccgggcaagagcaactcggtcgccgcatacactattctcagaatgacttggttgagtactcaccag
tcacagaaaagcatcttacggatggcatgacagtaagagaattatgcagtgctgccataaccatgagtgataacactgcggcca
acttacttctgacaacgatcggaggaccgaaggagctaaccgcttttttgcacaacatgggggatcatgtaactcgccttgatcgtt
gggaaccggagctgaatgaagccataccaaacgacgagcgtgacaccacgatgcctgtagcaatggcaacaacgttgcgca
aactattaactggcgaactacttactctagcttcccggcaacaattaatagactggatggaggcggataaagttgcaggaccactt
ctgcgctcggcgcttccggctggctggtttattgctgataaatctggagccggtgagcgtgggtctcgcggtatcattgcagcact
ggggccagatggtaagccctcccgtatcgtagttatctacacgacggggagtcaggcaactatggatgaacgaaatagacaga
tcgctgagataggtgcctcactgattaagcattggtaactgtcagaccaagtttactcatatatactttagattgatttaaaacttcattt
ttaatttaaaaggatctaggtgaagatcctttttgataatctcatgaccaaaatcccttaacgtgagttttcgttccactgagcgtcaga
ccccgtagaaaagatcaaaggatcttcttgagatcctttttttctgcgcgtaatctgctgcttgcaaacaaaaaaaccaccgctacc
agcggtggtttgtttgccggatcaagagctaccaactctttttccgaaggtaactggcttcagcagagcgcagataccaaatactg
ttcttctagtgtagccgtagttaggccaccacttcaagaactctgtagcaccgcctacatacctcgctctgctaatcctgttaccagt
ggctgctgccagtggcgataagtcgtgtcttaccgggttggactcaagacgatagttaccggataaggcgcagcggtcgggct
gaacggggggttcgtgcacacagcccagcttggagcgaacgacctacaccgaactgagatacctacagcgtgagctatgaga
aagcgccacgcttcccgaagggagaaaggcggacaggtatccggtaagcggcagggtcggaacaggagagcgcacgagg
gagcttccagggggaaacgcctggtatctttatagtcctgtcgggtttcgccacctctgacttgagcgtcgatttttgtgatgctcgt
caggggggcggagcctatggaaaaacgccagcaacgcggcctttttacggttcctggccttttgctggccttttgctcacatgac
ccgacaccatcgaatggcgcaaaacctttcgcggtatggcatgatagcgcccggaagagagtcaattcagggtggtgaatgtg
aaaccagtaacgttatacgatgtcgcagagtatgccggtgtctcttatcagaccgtttcccgcgtggtgaaccaggccagccacg
tttctgcgaaaacgcgggaaaaagtggaagcggcgatggcggagctgaattacattcccaaccgcgtggcacaacaactggc
gggcaaacagtcgttgctgattggcgttgccacctccagtctggccctgcacgcgccgtcgcaaattgtcgcggcgattaaatct
cgcgccgatcaactgggtgccagcgtggtggtgtcgatggtagaacgaagcggcgtcgaagcctgtaaagcggcggtgcac
aatcttctcgcgcaacgcgtcagtgggctgatcattaactatccgctggatgaccaggatgccattgctgtggaagctgcctgcac
  
61 
 
 
taatgttccggcgttatttcttgatgtctctgaccagacacccatcaacagtattattttctcccatgaagacggtacgcgactgggc
gtggagcatctggtcgcattgggtcaccagcaaatcgcgctgttagcgggcccattaagttctgtctcggcgcgtctgcgtctgg
ctggctggcataaatatctcactcgcaatcaaattcagccgatagcggaacgggaaggcgactggagtgccatgtccggttttca
acaaaccatgcaaatgctgaatgagggcatcgttcccactgcgatgctggttgccaacgatcagatggcgctgggcgcaatgc
gcgccattaccgagtccgggctgcgcgttggtgcggacatctcggtagtgggatacgacgataccgaagacagctcatgttata
tcccgccgttaaccaccatcaaacaggattttcgcctgctggggcaaaccagcgtggaccgcttgctgcaactctctcagggcc
aggcggtgaagggcaatcagctgttgcccgtctcactggtgaaaagaaaaaccaccctggcgcccaatacgcaaaccgcctct
ccccgcgcgttggccgattcattaatgcagctggcacgacaggtttcccgactggaaagcgggcagtgagcggtacccgataa
aagcggcttcctgacaggaggccgttttgttttgcagcccacctcaacgcaattaatgtgagttagctcactcattaggcacccca
ggctttacactttatgcttccggctcgtatgttgtgtggaattgtgagcggataacaatttcacacaggaaacagctatgaccatgat
tacgaatttctagataacgagggcaaatcatgaaatacctattgcctacggcggccgctggattgttattactcgcggcccagccg
gccatggcctcgnnknnknnknnknnknnktagggcccgggaggccaaggcggtggttctgagggtggtggctccctcg
agggcgcgccagccgaaactgttgaaagttgtttagcaaaacctcatacagaaaattcatttactaacgtctggaaagacgacaa
aactttagatcgttacgctaactatgagggctgtctgtggaatgctacaggcgttgtggtttgtactggtgacgaaactcagtgttac
ggtacatgggttcctattgggcttgctatccctgaaaatgagggtggtggctctgagggtggcggttctgagggtggcggttctga
gggtggcggtactaaacctcctgagtacggtgatacacctattccgggctatacttatatcaaccctctcgacggcacttatccgc
ctggtactgagcaaaaccccgctaatcctaatccttctcttgaggagtctcagcctcttaatactttcatgtttcagaataataggttcc
gaaataggcagggtgcattaactgtttatacgggcactgttactcaaggcactgaccccgttaaaacttattaccagtacactcctg
tatcatcaaaagccatgtatgacgcttactggaacggtaaattcagagactgcgctttccattctggctttaatgaggatccattcgtt
tgtgaatatcaaggccaatcgtctgacctgcctcaacctcctgtcaatgctggcggcggctctggtggtggttctggtggcggctc
tgagggtggcggctctgagggtggcggttctgagggtggcggctctgagggtggcggttccggtggcggctccggttccggt
gattttgattatgaaaaaatggcaaacgctaataagggggctatgaccgaaaatgccgatgaaaacgcgctacagtctgacgcta
aaggcaaacttgattctgtcgctactgattacggtgctgctatcgatggtttcattggtgacgtttccggccttgctaatggtaatggt
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gctactggtgattttgctggctctaattcccaaatggctcaagtcggtgacggtgataattcacctttaatgaataatttccgtcaatat
ttaccttctttgcctcagtcggttgaatgtcgcccttatgtctttggcgctggtaaaccatatgaattttctattgattgtgacaaaataaa
cttattccgtggtgtctttgcgtttcttttatatgttgccacctttatgtatgtattttcgacgtttgctaacatactgcgtaataaggagtct
taatcaagctttaatattttgttaaaattcgcgttaaatttttgttaaatcagctcattttttaaccaataggccgaaatcggcaaaatccc
ttataaatcaaaagaatagaccgagatagggttgagtgttgttccagtttggaacaagagtccactattaaagaacgtggactcca
acgtcaaagggcgaaaaaccgtctatcagggcgatggcccactacgtgaaccatcaccctaatcaagttttttggggtcgaggt
gccgtaaagcactaaatcggaaccctaaagggagcccccgatttagagcttgacggggaaagccggcgaacgtggcgagaa
aggaagggaagaaagcgaaaggagcgggcgctagggcgctggcaagtgtagcggtcacgctgcgcgtaaccaccacacc
cgccgcgcttaatgcgccgctacagggcgcgtcaggtg  (mutated sites are highlighted in red. n presents 
any of a, g, c, t, and k presents g or t) 
Construction of Phagemid Library 
The phagemid library was constructed and amplified by Polymerase chain reaction 
(PCR) using forward primer:  5'- GGT CCG ATG GCC NNK NNK NNK NNK NNK 
NNK GGC CCG GG -3', and reverse primer: 5'- CCA CGG CCA TGG CCG GCT GGG 
CCG CG -3'. The PCR product was digested by NCoI restriction enzyme, and ligated by 
T4 DNA ligase. The ligated plasmids were electroporated into competent Ecoli. Top10 
cell, incubated with 1 mL of LB medium and then inoculated into 5 mL of LB medium 
containing 100 μg/mL ampicillin. After OD600 reached 1.0, 0.5 mL of cell culture was 
mixed with with 50% glycerol and stored in -80 °C. Several of aliquots are made to for the 
total coverage of more than 1011 cfu. To collect the phagemids, normalized amount of cell 
stocks was used to guarantee equal amount of phagemids from each aliquot.   
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Phage Expression 
Q350 at M13KO7 was mutated to stop codon TAA to knock out expression of pIII 
protein from helper phage. Phagemid library constructed from previous step was electro-
porated into Ecoli. Top10 electro competent cells with M13KO7g3TAA and pEVOL-
CloDF-AcrkRS. Transformed cells were inoculated into 100 mL of 2YT medium. Fusion 
protein expression was induced with 0.2% arabinose, 0.5 mM IPTG, 2 mM AcrK when 
OD600 reached 0.5. After 12-hour induction, cell pellets were precipitated by centrifuge and 
discarded. The supernatants containing phages were precipitated by chilled polyethylene 
glycol, and then subjected to centrifuge (15 min, 10,000 g, 4 ℃). Phage pellets were 
collected and dissolved in PBS buffer. The total number of phage was calculated as 
following: 10 uL of phages was incubated at 65 oC water bath for 15 min to kill all Ecoli. 
Top10 cell. 90 uL of  Top10F’ (OD600 = 1.0) are infected by these phages and subjected to 
the agar plate with serial dilution for calculation. The total yield is around 1010 cfu per 100 
mL of LB medium, sufficient to cover library diversity (theoretical diversity of a 6-mer 
library is 20 = 6.4 x 106) 
 
5. Phage Selection Against TEV Protease and HDAC8 
For selection, streptavidin magnetic beads that only bind to biotin for selection were 
used. To generate biotinylated protein in aqueous solution, biotin sulfosuccinimidyl ester 
kit (thermos fisher scientific) was used since a succinimidyl ester moiety reacts w i t h  
primary amine group (Figure 22). A 15μM purified target protein was incubated with 
30μM biotin succinimidyl ester in 50 mM phosphate buffer for 2 hours at room 
temperature. The reaction was quenched with addition of 10 mM lysine and subjected to 
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the protein purification kit (Bio-RAD). 5 uM purified biotinylated protein are incubated 
with streptavidin magnetic beads (Pierce) for 1 hour in PBS buffer. Unreacted protein was 
washed away.   
 
 
 
Figure 22 Reaction between biotin succinimidyl ester and protein with primary amine 
 
In selection process, to remove individuals capable of non-specific binding, phage 
library was pre-incubated with only streptavidin magnetic beads for every round of 
selection. Later, phage library was incubated with protein-binding streptavidin magnetic 
beads for 10 min. The beads were washed 10 times by phosphate buffered saline with 
Tween-20 (PBST, 8mM Na2HPO4, 150mM NaCl, 3 mM KCl, 2mM KH2PO4, 0.05% 
Tween-20, pH 7.4), eluted with Glycine-HCl buffer (pH 2.2), and neutralized with Tris 
buffer (pH 9.1). Top10F’ cells were infected by the eluted phage to calculated the number 
of phage particles. To amplify the selected phage library, the phagemid from infected 
Top10F’ cells were extracted. Cell transformation, phage expression and phage selection 
were repeated for consecutive three rounds. For better comparison, controls of background 
binding phages with streptavidin magnetic beads were also studied in each round of 
selection.  
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Figure 23 illustrates the number of eluted phage for every round, of TEV protease 
and HDAC8, respectively. A dramatic increase of eluted phages was observed after three 
rounds, for both TEV protease and HDACs, while only a slightly enrichment of controls 
was observed. 
 
 
 
Figure 23 Number of eluted phages for TEV protease and HDAC8 in each selection round.  
Number of input   phages is 109 in each round.
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 6. Synthesis of Selected Peptide CX6-AcrK (X designates any canonical amino acid) 
General information 
With advantages such as high yield, ease of handling and simple isolation steps,  
solid phage peptide synthesis (SPPS) strategy has been demonstrated as the best alternative 
to synthesize peptides.79,82 In this strategy, the peptide sequences are synthesized from C-
terminal to N-terminal (Figure 24). Special resins are used as solid phase to couple amino 
acids one by one. The amino acids with protected side chains are coupled to the α-amino 
group. In this dissertation, Fmoc-protected amino acids were used in synthesis of selected. 
After the removal of Fmoc protecting group from N-terminal and activation of C-terminal, 
coupling of each amino acid is usually finished in a few minutes to a few hours. Unreacted 
reagents and byproducts were then washed away by DMF and dichloromethane. Finally, 
peptides were cleaved from resin by 95% TFA, precipitated by cold ether and subjected to 
further characterization. To monitor the coupling process, Kaiser test is the most commonly 
used approach. Similar to ninhydrin test, only primary amines turn blue when they reacts 
with Kaiser test kit (Figure 25).83,84  
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Figure 24 General procedure of solid phage peptide synthesis (SPPS) 
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Figure 25 Reaction of Kaiser test. 
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Couple the first lysine to the resin 
200 mg rink amide MBHA resin (Novabiochem) in DMF was added to a poly 
vessel, swelled for 1 h. Fmoc group of the resin was then deprotected by 20% (vol/vol) 
piperidine in DMF for 30 minutes, and then washed with DMF, dichloromethane (DCM) 
and methanol. Fmoc-Lys(mtt)-OH (4 equiv), tetramethyluronium hexafluorophosphate 
(HBTU, 4 equiv) and diisopropyl-ethylamine (DIEA, 10 equiv) were dissolved in DMF. 
The solution was added to the reaction vessel under nitrogen and mixed with the resin. 
Coupling was not finished until Kaiser-ninhydrin test became negative.   
Couple the remaining amino acids to the resin 
Fmoc-protected amino acids (4 equiv), tetramethyluronium hexafluorophosphate 
(HBTU, 4 equiv) and diisopropyl-ethylamine (DIEA, 10 equiv) were dissolved in DMF 
(10 mL). The solution was added to the reaction vessel under nitrogen and mixed with the 
resin. Reaction was not stopped until Kaiser-ninhydrin test became negative.  The last 
amino acid we used is Boc-Cys(trt)-OH. There is no additional deprotection steps after the 
final coupling.  
Synthesis of N-succinimidyl acrylate6 
To a solution of N-hydroxysuccinimide (1.3 g, 11.3 mmol) in anhydrous 
dichloromethane (25 mL) was added N,N-diisopropylethylamine (1.5 mL, 8.9 mmol), 
followed by dropwise addition of acryloyl chloride (0.8 mL, 9.3 mmol) in ice bath in 10 
min. The mixture was then stirred for 10 hours at room temperature. The mixture was 
extracted with 50 mL of ethyl acetate, washed with saturated NH4Cl solution (x3) and 
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brine, and dried with anhydrous Na2SO4. The solution was filtered and evaporated under 
vacuum to give a yellow oil (1.5 g).   
Couple N-succinimidyl acrylate to the first lysine 
After the coupling of cysteine, use % TFA in dichloromethane (vol/vol) and 1% 
triisopropylsilane (TIS) in dichloromethane (vol/vol) to remove -mtt group. N-
Succinimidyl acrylate (2 equiv) and DIEA (5 equiv) in DMF were added to the resin and 
coupled until Kaiser test became negative.  
Cleavage of the peptide from the resin 
4 mL of cleavage solution containing 92.5% trifluoroacetic acid (TFA), 2.5% TIS, 
2.5% water, 2.5% 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) was incubated 
with 200 mg resin for 2~3 hours.  The peptide products were precipitated with 10 volume 
cold diethyl ether. The cleaved peptides were collected by centrifuge, washed with cold 
diethyl ether and purified by HPLC. The purified products were lyophilized and subjected 
to MALDI-TOF analysis. 
Preparation of cyclic peptide 
Purified peptide was dissolved in PBS buffer and incubated at room temperature 
for 4 hours, and subjected to HPCL for purification. Eluted peptide solution was 
lyophilized to give a white powder. Compared to linear peptides, 1H NMR shows the 
appearance of  δ 5.89 (m, 1H), proving the success of cyclization between side chain of 
cysteine and the acryloyl moiety of AcrK.  
  
  
71 
 
 
 
  
 
 
 
Figure 26  MALDI-TOF spectrum of CQWFSHR-AcrK, M.W.:1144.02 g/mol 
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Figure 27  MALDI-TOF spectrum of CGTWLKF-AcrK, M.W.:1035.28 g/mol 
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Figure 28  MALDI-TOF spectrum of CWRDYLI-AcrK, M.W.:1149.38 g/mol 
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Figure 29  1H NMR spectrum for cyclo(CWRDYLI-AcrK) 
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7. Fluorescence Polarization Measurement 
Synthesis of 5-carboxyfluorescein (FAM) -conjugated peptide (CX6-AcrK-K(5-FAM), X 
designates any amino acid) 
Couple the first lysine to the resin: 200 mg rink amide MBHA resin (Novabiochem) 
in DMF was added to a poly vessel, swelled for 1 h. Fmoc group of the resin was then 
deprotected by 20% (vol/vol) piperidine in Dimethylformamide (DMF) for 30 minutes, 
and then washed with DMF, dichloromethane (DCM) and methanol. Fmoc-Lys(mtt)-OH 
(4 equiv), tetramethyluronium hexafluorophosphate (HBTU, 4 equiv) and diisopropyl-
ethylamine (DIEA, 10 equiv) were dissolved in DMF. The solution was added to the 
reaction vessel under nitrogen and mixed with the resin. Coupling was not finished until 
Kaiser-ninhydrin test became negative.     
Couple 5-Carboxyfluorescein to lysine: -Mtt protecting group from the first lysine 
was removed by repeated washing of 1% TFA in dichloromethane (vol/vol) and 1% 
triisopropylsilane (TIS) in dichloromethane (vol/vol). Couple 5-Carboxyfluorescein (2 
equiv) and DIEA (5 equiv) in DMF were added to the resin and coupled until Kaiser test 
became negative. 
Couple the remaining amino acids to the resin: Fmoc-protected amino acids (4 
equiv), tetramethyluronium hexafluorophosphate (HBTU, 4 equiv) and diisopropyl-
ethylamine (DIEA, 10 equiv) were dissolved in DMF. The solution was added to the 
reaction vessel under nitrogen and mixed with the resin. Reaction was not finished until 
Kaiser-ninhydrin test became negative.  The last amino acid we used is Boc-Cys(trt)-OH. 
There is no additional deprotection steps after the final coupling.  
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Couple N-Succinimidyl acrylate to the second lysine: after the coupling of cysteine, 
use % TFA in dichloromethane (vol/vol) and 1% triisopropylsilane (TIS) in 
dichloromethane (vol/vol) to remove -mtt group from the second lysine. N-Succinimidyl 
acrylate (2 equiv) and DIEA (5 equiv) in DMF were added to the resin and coupled until 
Kaiser test became negative.  
Cleavage of the peptide from the resin: 4 mL of cleavage solution containing 92.5% 
trifluoroacetic acid (TFA), 2.5% TIS, 2.5% water, 2.5% 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) was incubated with 200 mg resin for 2 hours.  
The peptide products were precipitated with 10 volume cold diethyl ether. The cleaved 
peptides were collected by centrifuge, washed with cold diethyl ether and subjected to 
HPCL for purification. The purified products were lyophilized and subjected to MALDI-
TOF analysis. 
Preparetion of cyclic peptide: Purified peptide was dissolved in PBS buffer and 
incubated at room temperature for 4 hours, and subjected to HPCL for purification. Eluted 
peptide solution was lyophilized to give a white powder. 
Fluorescence polarization measurement 
25 nM 5-FAM-conjugated cyclic peptide and different concertation of target 
proteins (160 nM to 160 µM) were incubated at black 96-well plates. PBS buffer were 
added to make the final volume 200 µL in each well. Fluorescence polarization was 
measured by a microplate reader at Ex/Em = 490 nm / 520 nm.  
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8. I50 Value Measurement 
Synthesis of Boc-lys(Ac)-AMC 85 
Boc-lys(Ac)-OH (2.0 mmol, 576.7 mg) and 7-Amino-4-methylcoumarin (2.0 
mmol,350.4 mg) were dissolved in ice-chilled anhydrous THF (50 mL). Pyridine (20.0 
mmol, 1.6 mL) was added to the solution dropwise, followed by the addition of phosphoryl 
chloride (8.4 mmol, 0.8 mL). The mixture was stirred in ice-water bath for 3 hours. Later, 
the reaction was quenched by the addition of saturated sodium bicarbonate solution (50 
mL). The mixture was concentrated to 50 mL under reduced pressure. The mixture was 
extracted with 25 mL dichloromethane for three times, and washed with 25 mL saturated 
NaCl solution and 0.5 M HCl solution (4 x 50 mL). The combined dichloromethane 
extraction was dried over anhydrous MgSO4, concentrated under reduced pressure, and 
dissolved in HCl/MeOH (1:4 v/v). The solution was stirred at room temperature for 24 
hours and concentrated under reduced pressure, affording desired product (489.1 mg, 55% 
for two steps) as a yellow powder.   
 
 
Figure 30 Synthesis of Boc-Lys(Ac)-AMC 
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IC50 value measurement  
Peptide CQSLWMN-AcrK was pre-incubated at PBS buffer for 4 hours for 
cyclization, generating cyclo(CQSLWMN-AcrK). Different concentrations (1 nM – 1000  
µM) of cyclo(CQSLWMN-AcrK) and 5 µM HDAC8 were added to a black 96-well plate 
(Pierce). PBS buffer was added to make the final volume in each well 200 µL. The plate 
was incubated at 30℃ for 10 min. 50 µM Boc-Lys(Ac)-AMC was added to each well. 
After 1-hour incubation at 30℃, the HDAC-catalyzed deacetylation was terminated by 
addition of trichostatin A (TSA, 1 µM), followed by addition of trypsin (0.5 mg/mL) to the 
reaction solution. After additional 1-hour incubation at 30℃, the fluorescence of coumarin 
was measured by a microplate reader with Ex/Em = 360 nm/ 460 nm. Experiments of IC50 
measurements were repeated three times.  
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Figure 31 MALDI-TOF spectrum of CWRDYLI-AcrK-K(5-FAM), M.W.: 1636 g/mol 
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Figure 32 MALDI-TOF spectrum of CWRDYLIKK(5-FAM), M.W.: 1581 g/mol 
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Figure 33 MALDI-TOF spectrum of CWRDYLI-AcrK-K(5-FAM), M.W.: 1631 g/mol 
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Figure 34  MALDI-TOF spectrum of CWRDYLIK-K(5-FAM), M.W.: 1575 g/mol 
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Figure 35  MALDI-TOF spectrum of CQSLWMN-AcrK-K(5-FAM), M.W.: 1549 g/mol 
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Figure 36  MALDI-TOF spectrum of CQSLWMNK-K(5-FAM), M.W.: 1493 g/mol 
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Figure 37  1H NMR spectrum for Boc-Lys(Ac)-AMC 
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Results and Discussion 
 
1. Characterization of 1, 4-cycloaddition in sfGFP 
Before the construction of peptide libraries, we firstly tested 1, 4-cycloaddition 
between cysteine and the acrylamide moiety in model protein Met-Cys-(Ala)5-AcrK-
sfGFP and Met-Cys-(Ala)5-CrtK-sfGFP, respectively. Nε-acryloyl-L-lysine (AcrK) and 
Nε-crotonyl-L-lysine (CrtK) (Figure 38), two NCAAs both bearing an acrylamide moiety, 
were incorporated at amber TAG position by two mutants of PylRS, PrKRS (Y384W 
MmAcKRS1 mutant) and BuKRS (Y384W PylRS mutant), respectively. For better 
comparison, another two sfGFP mutants without cysteine, Met-(Ala)6-AcrK-sfGFP and 
Met-(Ala)6-CrtK-sfGFP, were generated in the same way and used as linear controls. 
Theoretically, these two linear controls have no free cysteine and cannot undergo 
cyclization. 
 
Figure 38 Structure of AcrK and CrtK. 
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To test the success of cyclization, hydrozonoyl chloride 1 acts as a fluorogenic 
probe. If there is any unreacted acrylamide moiety in Met-Cys-(Ala)5-AcrK-sfGFP or Met-
Cys -(Ala)5-CrtK-sfGFP, the remaining acrylamide moiety undergoes a fluorescence turn-
on nitrile imine cycloaddition a with hydrozonoyl chloride 1, leading to a fluorescent 
cycloaddition product from those non-fluorescence starting materials (Figure 39A). 
Thereby monitoring fluorescence is an approach to detect the cyclization process. Details 
of this nitrile imine cycloaddition have been demonstrated in Chapter II. The best condition 
for the reaction is in acetonitrile-50 mM phosphate buffer ( vol/vol = 1:1) at pH 10. The 
reaction is very efficient and can be finished in one minute. In this way, sfGFP mutants 
bearing AcrK and CrtK were both incubated with hydrozonoyl chloride in acetonitrile-50 
mM phosphate buffer (1:1), pH 10 for 10 min, and then subjected to SDS page analysis 
(Figure 39B). Both Met-Cys-(Ala)5-AcrK-sfGFP(a) and Met-Cys-(Ala)5-CrtK-sfGFP (d) 
show no fluorescence, verifying that the cyclization through 1,4-addition is already 
completed during sfGFP expression and purification steps. In contrast, both of the two 
sfGFP mutants without cysteine show fluorescence. Additionally, the linear sfGFP mutants 
incorporated with CrtK shows weaker fluorescence than the mutants with AcrK, 
demonstrating the fact that CrtK was less reactive that AcrK. This is because the methyl 
group in CrtK residue hinders the attack from cysteine thiol due to steric effect, and thus 
the reaction rate of CrtK with hydrozonoyl chloride is slower than that of AcrK.  
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Figure 39 (A) Click reaction between hydrozonoyl chloride and alkene; (B) SDS-Page 
analysis of a. Met-Cys-(Ala)5-AcrK-sfGFP and control b. Met-(Ala)6-AcrK-sfGFP, control 
c.Met-(Ala)6-CrtK-sfGFP and d. Met-Cys-(Ala)5-CrtK-sfGFP after reaction with 
hydrozonoyl chloride in acetonitrile-50 mM phosphate buffer (1:1) with pH 10. The top 
gels were stained by Coomassie blue; the bottom are the same gels but visualized by 
fluorescence before stained by Coomassie blue. 
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2. Construction of Phage-displayed Cyclic Peptide Library  
Encouraged by the success of cyclization reactions on model proteins, we extended 
this approach to the construction of phage-displayed cyclic peptide library bearing a 
conserved cysteine and AcrK. To incorporate NCAAs into phage library, our lab has 
developed a strategy based on the amber stop codon suppression. In our methodology, 
pADLg3 phagemid was used to produce full-length pIII coat protein, where the foreign 
peptide incorporated with an NCAA is fused to. Compared to the other phage vectors, 
pADL phagemids have notable advantages such as low contamination risk, PelB secretion 
and single pDNA package. A helper phage lacking pIII is required to pack phagemid, and 
guarantee that the only pIII derived from pADL phagemid. After transformation with cells 
(e.g. Escherichia coli) and expression, single-strand phagemid DNA is infected by helper 
phages and efficiently packed into viral particles. Then the packed fusion proteins will be 
released from host cells.  
For the genetic construction, pADL library, a TAG-enriched M13 phagemid library 
of pIII fusion proteins, was constructed by flanking diversity of 6 residue positions between 
a cysteine codon and the amber stop codon, each residue position randomizing 20 canonical 
amino acids. Polymerase chain reaction (PCR) enables the insertion of six randomized 
codons (NNKs) between pelB and pIII in the pADL phagemid. The amino acid sequence 
is: (PelB)-Ala-Cys-(Xxx)6-TAG-(pIII) (Xxx designates a randomized canonical amino 
acid). More than 109 clones were obtained to guarantee the coverage for the possibility of 
all 20 amino acids at each randomized position (206 = 6.4x107).  
Next, we investigated the expression of phage library. Given that two plasmids with 
a same replication origin are incompatible during expression, CloDF origin was used 
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instead of p15A in synthetase plasmid to avoid the conflict, since the helper phage M13K07 
has a p15A origin. To incorporate AcrK into the phage library, synthetase plasmid pEVOL-
CloDF-PrKRS were constructed, as reported previously.6 The M13K07 helper phage is 
used for phage assembly and infectivity during expression to generate a fusion peptide on 
the phage surface. In addition, genetic modification of helper phages is necessary for the 
pIII knockout to guarantee that pIII only comes from phagemid. Herein, we mutated Q350 
to stop codon TAA to delete pIII from helper phage. The cloned pADLg3 phagemid, 
M13K07g3TAA and the synthetase plasmid were electroporated into E. Coli Top10 
competent cells and expressed with AcrK. Thus, the pIII fusion Ala-Cys-(Xxx)6-AcrK 
peptide was displayed on the surface of M13 filamentous phage and cyclized through 1,4-
addition between cysteine and AcrK. The expression yield for purified phage is 1010 
colony-forming units/L. 
 
3. Screening a Phage-displayed Cyclic Library Against Target Proteins: TEV Protease 
and HDAC8 
With the 6-mer cyclic phage library in hand, we performed the selection against 
two target proteins: a well-studied target protein tobacco etch virus (TEV) protease and a 
cancer related protein HDAC8, respectively. A biotin capture reagent, here biotin-
sulfosuccinimidyl ester, which could react with a primary amine, was used for the 
biotinylation of target proteins. Next, the 6-mer cyclic phage library with more than 109 
different pIII fusion peptides was subjected to three consecutive rounds of selection against 
two biotinylated target proteins immobilized on streptavidin magnetic beads, respectively. 
To remove impact from non-specific binding, phage was pre-incubated with streptavidin 
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magnetic beads before every round of selection. After each round of selection, Top10F’ 
cells are infected by the selected phage, and were used to extract selected phagemid DNA. 
Next, these selected phagemids were amplified, and then subjected to the next round of 
selection (Figure 40).  
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Figure 40  Phage generation and amplification 
 
 
 
 
 
Figure 41  General process of phage selection  
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After three rounds of selection against streptavidin mobilized biotinylated-TEV 
protease, dramatically enriched phage-displayed peptide sequences were observed. Eluted 
number of phages increase 250 folds from the first round to the last round. A number of 
clones were chosen and sent for DNA sequencing to identify the sequences. Sequencing 
results show that the cyclic peptide sequence, CWRDYLI-AcrK, is the most abundant 
sequence, followed by CQWFSHR-AcrK and CGTWLKF-AcrK (Table 1). Later these 
three peptide sequences were synthesized through solid phase peptide synthesis (SPPS) 
method. Solid phase peptide synthesis is based on a solid resin and synthesized from C-
terminal to N-terminal using N-terminal protected amino acids. HPLC allows the 
purification of the final peptide products. Isothermal thermal titration (ITC) was used to 
characterize the binding affinity between selected cyclic peptides and target protein TEV 
protease.  
For selection against HDAC8, phage enrichment was also observed after three 
rounds of selection against streptavidin mobilized succinimidyl-HDAC8. Eluted number 
of phage particles increases from 40 folds from the first round to the third round. Out of all 
identified phagemids sequence, CQSLWMN-AcrK is the most abundant sequence, 
followed by CKHSLWV-AcrK and CLSDCRU-AcrK (Table 1). 
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Table 1 Selected peptide sequencing result* 
Target protein Peptide Number of clones 
TEV protease 
 
CWRDYLI-AcrK 10 
CQWFSHR-AcrK 8 
CGTWLKF-AcrK 7 
HDAC8 CQSLWMN-AcrK 8 
CKHSLWV-AcrK 2 
CLSDCRU-AcrK 1 
*36 clones were sequenced after the 3rd round of selections. 
 
4. Fluorescence Polarization Study of HDAC8 and TEV Protease 
Having identified the selected peptide sequence, we characterized interaction and 
inhibition ability of them against target proteins. Fluorescence polarization (FP) is a 
sensitive nonradioactive approach for the measurement of interactions between 
macromolecules when one of the reactant is relatively small and fluorophore-labeled. 
When excited by polarized light, the fluorescent labeled molecule emits light with a degree 
of polarization that is inversely proportional to the molecular rotation of fluorophore-
labeled molecule.86 Moreover, the molecular rotation is related to the molecular weight. A 
lager molecule has a slower rotation.86,87 Thus, when a small fluorophore binds to a 
macromolecule, association rate or dissociation rate could be determined by monitoring 
the change of polarization. In general, a small fluorophore is less than 1500 Da. Sometimes 
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a fluorophore can be up 5000 Da if the binding protein is much larger than itself. 
Quantitatively, FP is termed as the difference between the parallel and perpendicular 
emission intensity divided by the total of the parallel and perpendicular emission intensity: 
FP = (Iparallel - Iperpendicular) / (Iparallel - Iperpendicular) 
where Iparallel is the intensity of emission light which is parallel to the excitation light plane 
and Iperpendicular is the intensity of emission light which is perpendicular to the excitation 
light plane. 
 
 
 
 
Figure 42 Mechanism of fluorescence polarization 
 
 
  
  
96 
 
 
In this dissertation, small peptides conjugated with 5-FAM fluorophore were used 
as fluorescence polarization assay. For TEV protease, we chose two most abundant peptide 
sequences and synthesized their fluorophore-labeled derivatives: cyclo(CWRDYLI-AcrK-
K(5-FAM)) and cyclo(CQWFSHR-AcrK-K(5-FAM)). For HDAC8, we chose the most 
abundant peptide and synthesized its fluorophore-labeled derivative: cyclo(CQSLWMN-
AcrK-K(5-FAM)). At the same time, linear counterparts without acryloyl group on the 
lysine were also synthesized as linear controls. To determine the interaction between 
fluorophore-labeled peptide probes and target proteins, fluorophore-labeled peptide probes 
in PBS buffer were added into a 96-well, black-bottom plate. Increasing concentrations of 
target proteins were added to different well, and mixed with previously added fluorophore-
labeled peptide probe. The total reaction volume in each well is 200 uL. The final 
concentration of each fluorophore-labeled peptide probe is fixed to 25 nM, while the final 
concentration of each target proteins ranges from 100 nM to 120 µM. The plates were 
subjected to BioTek Synergy H1 microplate reader, with a 490 nm excitation filter and a 
520 nm emission filter at 30 °C.  
The shape of relation curve of polarization and protein concentration is sigmoidal. 
From the curve of polarization vs protein concentration, dissociation rate (kd) was 
calculated. Compared to liner counterparts without acryloyl group in the lysine, all 
fluorophore-labeled cyclic peptide probes have better binding affinity with 5-7 folds 
smaller kd (Figure 43). Thus, we have established a methodology for the discovery of 
cyclic peptide inhibitors with significant increased affinity and better specificity. 
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Figure 43  (A) Selected cyclic peptides conjugated to 5-FAM fluorophore as FP probes (2 
- 4); linear peptides conjugated to 5-FAM fluorophore as FP probes (5 - 7). (B) Binding 
affinity of FP probes (2-7) to TEV protease and HDAC8.  
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Figure 44 Fluorescence polarization measurement of cyclic peptides CWRDYLI-AcrK-
K(5-FAM) and CQWFSHR-AcrK-K(5-FAM) with TEV Protease 
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Figure 45 Fluorescence polarization measurement of linear peptides CWRDYLIK-K(5-
FAM) and CQWFSHRK-K(5-FAM) with TEV protease 
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Figure 46 Fluorescence polarization measurement of cyclic peptide CQSLWMN-AcrK-
K(5-FAM) with HDAC8 
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Figure 47 Fluorescence polarization measurement of linear peptide CQSLWMNK-K(5-
FAM) with HDAC8 
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Figure 48 Fluorescence polarization measurement of cyclic peptide CWRDYLI-AcrK-
K(5-FAM) with HDAC8 
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5. Inhibition Ability Measurement 
Inhibition ability of selected peptide with HDAC8 was investigated by the 
measurement of half maximal inhibitory concentration (IC50 value). In this dissertation, a 
fluorophore 7-Amino-4-methylcoumarin (AMC) derivative,  Boc-lys(Ac)-AMC, was used 
to obtain IC50 value of HDAC8.85,88,89 Boc-lys(Ac)-AMC was synthesized from α-BOC-ε-
acetyl lysine and 7-Amino-4-methylcoum using POCl3 and pyridine.90 Different 
concentrations ranging from 1 nM to 100 µM of selected cyclic peptide,  CQSLWMN-
AcrK, were mixed with 2 µM of purified HDAC8 in black 96-well plate. PBS buffer was 
added to make the total reaction volume in each well 200 µL. 50 µM Boc-lys(Ac)-AMC 
was added to the solution. After 1 hour incubation, 2 µM TSA was added to the solution 
to stop the HDAC8 inhibition activity, followed by the addition of trypsin (0.5 mg/mL). 
The plate was incubated at 30 °C for 2 hours, allowing the cleavage of trypsin of 
deacetylated assay and releasing free AMC fluorophore. Intensity was normalized for the 
inhibition ability. IC50 value for CQSLWMN-AcrK against HDAC8 is 9.7±0.4 µM. 
Compared to well-studied HDAC inhibitors such as SAHA (IC50 = 306 nM ) and TSA 
(IC50 = 110 nM ), the inhibition ability is not very strong.91 However, as the library only 
contains 6 randomized amino acids, the inhibition ability for this small size library is good. 
We expect by screening against a cyclic phage library with more positions with randomized 
amino acids, potential inhibitors would be selected with lower IC50 value and increased 
inhibition ability.   
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Figure 49 Scheme of Boc-Lys(Ac)-AMC assay. Inhibition activity is determined by 
monitoring fluorescence form methylcoumarin fluorophores. 
 
 
O ON
H
O
HN
H
N
O
O
O
Boc-Lys(Ac)-AMC
HDAC
acetate
O ON
H
O
HN
+H3N
O
O
Typsin
O OH2N
HN
O
OH
O
O
+H3N Ex = 360 nm
Em = 460 nm
  
105 
 
 
 
 
 
 
Figure 50 I50 measurement of cyclic peptide CQSLWMN-AcrK with HDAC8 
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CHAPTER IV 
CONCLUSIONS 
 
In the first part of this study, we proposed a mechanism for nitrile-imine 
cycloaddition in the absence of chloride. Then we performed a serial of kinetic study and 
protein labeling experiment, demonstrating that the nitrile imine cycloaddition is an ultra 
rapid reaction. Also, we found an optimized reaction condition, pH 10 without chloride, 
for efficient protein labeling which can be finished in 1 min.  
In the second part, we have established a methodology to select bivalent inhibition 
ligands from cyclic phage library against specific target proteins with high affinity, better 
specificity and increased inhibition ability. In this study, we incorporated non-canonical 
amino acid AcrK and constructed 6-mer cyclic peptide phage library. The cyclization was 
through 1,4-addition between cysteine and acryloyl moiety. Phage display methodology 
was used for the selection of target proteins via three consecutive rounds of screening 
against streptavidin mobilized biotinylated TEV protease and biotinylated HDAC8, 
respectively. Fluorescence polarization measurements have indicated the high specificity 
and affinity of selected peptides with target proteins. IC50 value of selected peptide, 
CQSLWMN-AcrK, against HDAC8 is 9.7 ± 0.4 µM. We expect larger library such as 12-
mer cyclic phage library would have increased inhibition ability. Also, further studies will 
focus on inhibition mode based on protein structure, cellular permeability and delivery, 
and in vivo study. Moreover, we will also apply this methodology to discover peptide-based 
drugs for more HDACs and other human disease related proteins. 
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